<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Forbes.com Healthcare News via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Forbes.com Healthcare News' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Forbes.com+Healthcare+News&t=Forbes.com+Healthcare+News&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 01:31:31 +0100</lastBuildDate>
        <item>
            <title>Prominent Interventionalists Attack Appropriate Use Criteria For PCI</title>
            <link>http://www.medworm.com/index.php?rid=5669341&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F02%2F08%2Fprominent-interventionalists-attack-appropriate-use-criteria-for-pci%2F</link>
            <description>A group of leading interventional cardiologists has launched an attack on the growing role of appropriate use criteria (AUC) for PCI in the US. They argue that severe flaws in current guidelines render unreliable current attempts to assess the rate of appropriate procedures. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669341</comments>
            <pubDate>Wed, 08 Feb 2012 21:02:26 +0100</pubDate>
            <guid isPermaLink="false">5669341</guid>        </item>
        <item>
            <title>10 Reasons Why the Komen Foundation Should Stop Lying About Its Motives</title>
            <link>http://www.medworm.com/index.php?rid=5669342&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcvharquail%2F2012%2F02%2F08%2F10-reasons-why-the-komen-foundation-should-stop-lying-about-its-motives%2F</link>
            <description>It always hurts when organizations lie.
Lying hurts the organization, the employees, the organization's partners, the organization's prospects, and most importantly, lying hurts the organization's constituents. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669342</comments>
            <pubDate>Wed, 08 Feb 2012 20:00:33 +0100</pubDate>
            <guid isPermaLink="false">5669342</guid>        </item>
        <item>
            <title>HealthTap: &quot;The Emperor's New Clothes&quot; of Social Sites</title>
            <link>http://www.medworm.com/index.php?rid=5669343&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmichaelmillenson%2F2012%2F02%2F08%2Fhealthtap-the-emperors-new-clothes-of-social-sites%2F</link>
            <description>You can’t get much cooler than HealthTap: slick Silicon Valley start-up, social media darling, savvy and successful backers. But when you closely examine the service HealthTap actually provides, the money and good looks fall away. Like in the fable about “the emperor’s new clothes,” behind the buzz, there’s nothing there. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669343</comments>
            <pubDate>Wed, 08 Feb 2012 17:54:52 +0100</pubDate>
            <guid isPermaLink="false">5669343</guid>        </item>
        <item>
            <title>Karen Handel Exits Susan G. Komen: The Resignation Letter</title>
            <link>http://www.medworm.com/index.php?rid=5669344&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmeghancasserly%2F2012%2F02%2F07%2Fkaren-handel-exits-susan-g-komen-the-resignation-letter%2F</link>
            <description>This morning Karen Handel, Susan G. Komen's controversial vice president of public policy announced this morning that she would resign from the breast cancer charity and would decline any offer of a severance package. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669344</comments>
            <pubDate>Wed, 08 Feb 2012 16:07:01 +0100</pubDate>
            <guid isPermaLink="false">5669344</guid>        </item>
        <item>
            <title>How to Score Big Branding Wins</title>
            <link>http://www.medworm.com/index.php?rid=5669345&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fjerrymclaughlin%2F2012%2F02%2F07%2Fhow-to-score-big-branding-wins%2F</link>
            <description>The other week, I exchanged emails with a reader in Atlanta who has worked himself into a tough spot.&amp;nbsp; He has invested his savings and a couple of years of his life into building a mobile phone application that people are not yet using in the numbers he needs to turn a profit.&amp;nbsp; He feels he is running out of money, time, and maybe enthusiasm.&amp;nbsp; He wrote privately for advice.&amp;nbsp; I hope I helped. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669345</comments>
            <pubDate>Tue, 07 Feb 2012 22:09:45 +0100</pubDate>
            <guid isPermaLink="false">5669345</guid>        </item>
        <item>
            <title>The Tortuous History of Conservatives and the Individual Mandate</title>
            <link>http://www.medworm.com/index.php?rid=5669346&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F02%2F07%2Fthe-tortuous-conservative-history-of-the-individual-mandate%2F</link>
            <description>Mitt Romney, as we know, has been catching a lot of flak from conservatives for Romneycare, because Romney’s signature legislative achievement served as the model for Obamacare. But as Romney said in a debate in Las Vegas last October, “we got the idea of an individual mandate…from , and got it from the Heritage Foundation.” Politically, it’s an important point, because Romney is inaccurately being portrayed as some kind of left-wing outlier, when in fact there were some major conservative institutions (like Heritage) and figures (like Gingrich) who supported the mandate. Last weekend, long-time Heritage health-policy chief Stuart Butler took to USA Today to explain his past support for the mandate. I took the occasion to dig into the topic, and found that the mandate's provenanc...</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669346</comments>
            <pubDate>Tue, 07 Feb 2012 20:32:34 +0100</pubDate>
            <guid isPermaLink="false">5669346</guid>        </item>
        <item>
            <title>Bleeding Problems Continue To Bedevil Merck's Novel Antiplatelet Agent Vorapaxar</title>
            <link>http://www.medworm.com/index.php?rid=5669347&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F02%2F07%2Fbleeding-problems-continue-to-bedevil-mercks-novel-antiplatelet-agent-vorapaxar%2F</link>
            <description>In the large&amp;nbsp;TRA-2P study of more than 26,000 patients with &amp;nbsp;MI, ischemic stroke, or documented peripheral vascular disease,&amp;nbsp;the novel antiplatelet agent vorapaxar significantly reduced the primary endpoint of CV death, MI, stroke or urgent coronary revascularization. But vorapaxar treatment resulted in a significant increase in bleeding, including intracranial hemorrhage. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669347</comments>
            <pubDate>Tue, 07 Feb 2012 15:22:41 +0100</pubDate>
            <guid isPermaLink="false">5669347</guid>        </item>
        <item>
            <title>Merck Blood Thinner Still Wild Card For Investors</title>
            <link>http://www.medworm.com/index.php?rid=5669348&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F02%2F07%2Fmerck-release-doesnt-tell-investors-what-they-need-to-know%2F</link>
            <description>Merck issued a press release saying that a second clinical trial of its blood-thinner vorapaxar prevented clot-related problems such as heart attacks, but also caused bleeding, including bleeding in the brain. The big question, which won't be answered until the full data are presented, is whether those risks and benefits balance out in a way that will result in a drug that will generate much in the way of sales. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669348</comments>
            <pubDate>Tue, 07 Feb 2012 15:11:11 +0100</pubDate>
            <guid isPermaLink="false">5669348</guid>        </item>
        <item>
            <title>Getting Better: Online Communities Elevate Voice of the Patient</title>
            <link>http://www.medworm.com/index.php?rid=5669349&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidshaywitz%2F2012%2F02%2F07%2Fgetting-better-online-communities-elevate-voice-of-the-patient%2F</link>
            <description>In my last column, I discussed the need for a better way of connecting the discrete healthcare-related problems identified by patients and physicians with solvers who might be able to develop a solution – perhaps an immediate fix, perhaps a longer-term effort. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669349</comments>
            <pubDate>Tue, 07 Feb 2012 07:39:38 +0100</pubDate>
            <guid isPermaLink="false">5669349</guid>        </item>
        <item>
            <title>Women and ICDs: More Complications and Fewer Benefits</title>
            <link>http://www.medworm.com/index.php?rid=5669350&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F02%2F06%2Fafter-consulting-an-electrophysiologist-women-are-just-as-likely-as-men-to-receive-an-icd-but-they-suffer-more-complications-and-are-less-likely-to-benefit-from-the-device-according-to-a-new-study-f%2F</link>
            <description>After consulting an electrophysiologist, women are just as likely as men to receive an ICD but they suffer more complications and are less likely to benefit from the device, according to a new study from Canada published in Annals of Internal Medicine. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669350</comments>
            <pubDate>Mon, 06 Feb 2012 22:14:13 +0100</pubDate>
            <guid isPermaLink="false">5669350</guid>        </item>
        <item>
            <title>Your Brain May Be &quot;Wired&quot; For Addiction (But You Don't Have To Surrender)</title>
            <link>http://www.medworm.com/index.php?rid=5669351&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Falicegwalton%2F2012%2F02%2F06%2Fyour-brain-may-be-wired-for-addiction-but-you-dont-have-to-surrender%2F</link>
            <description>Addiction is one of the most common mental health problems there is: Drug use alone affects tens of millions of Americans, and that's only the illegal ones. Even more people deal with addictions to other things – alcohol, caffeine, nicotine, food, and various behaviors. People who are familiar with addiction, and certainly the researchers who study it, may wonder whether their brains are fundamentally different from non-addicts, making them more prone to addiction’s grasp. Now, a new study offers an interesting answer to this very basic question. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669351</comments>
            <pubDate>Mon, 06 Feb 2012 16:39:23 +0100</pubDate>
            <guid isPermaLink="false">5669351</guid>        </item>
        <item>
            <title>Facebook Power Users? What About the Power Shouters</title>
            <link>http://www.medworm.com/index.php?rid=5661312&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ferikamorphy%2F2012%2F02%2F05%2Ffacebook-power-users-what-about-the-power-shouters%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661312</comments>
            <pubDate>Sun, 05 Feb 2012 23:06:39 +0100</pubDate>
            <guid isPermaLink="false">5661312</guid>        </item>
        <item>
            <title>Empowering Consumers: A Fantastic Voyage To Unseen Information</title>
            <link>http://www.medworm.com/index.php?rid=5661313&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ftoddessig%2F2012%2F02%2F04%2Fempowering-consumers-a-fantastic-voyage-to-unseen-information%2F</link>
            <description>Stefani Bardin is an artist whose latest project is an important contribution to the cause of helping people make more informed—and therefore healthier and more pleasurable—food choices, a cause that simultaneously creates opportunities for sustainable food businesses nimble enough to serve the needs of increasingly empowered consumers. I saw her latest video, the one posted below, a couple of weeks ago at the TEDxManhattan “Changing the Way We Eat” conference organized by Diane Hatz of The Glynwood Institute for Sustainable Food and Farming. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661313</comments>
            <pubDate>Sat, 04 Feb 2012 18:01:04 +0100</pubDate>
            <guid isPermaLink="false">5661313</guid>        </item>
        <item>
            <title>Is Your K-Y Jelly Cruelty-Free? Do You Care?</title>
            <link>http://www.medworm.com/index.php?rid=5661314&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fvickeryeckhoff%2F2012%2F02%2F03%2Fis-your-k-y-jelly-cruelty-free-do-you-care%2F</link>
            <description>If animal testing is at odds with your values, there's something you can do to stop it. Nothing radical, just a little brand switching—and you don’t have to forgo shiny hair, lips and floors to do it. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661314</comments>
            <pubDate>Fri, 03 Feb 2012 22:28:56 +0100</pubDate>
            <guid isPermaLink="false">5661314</guid>        </item>
        <item>
            <title>Friday Reads, Part 2: Komen Apologizes and Pfizer Recalls Contraceptives</title>
            <link>http://www.medworm.com/index.php?rid=5661315&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmickeymeece%2F2012%2F02%2F03%2Ffriday-reads-part-2-komen-apologizes-and-pfizer-recalls-contraceptives%2F</link>
            <description>First SOPA and now the Susan G. Komen for the Cure Foundation -- chalk up another social media victory this year. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661315</comments>
            <pubDate>Fri, 03 Feb 2012 19:01:15 +0100</pubDate>
            <guid isPermaLink="false">5661315</guid>        </item>
        <item>
            <title>Komen Caves Under Pressure, Reinstates PP Funding</title>
            <link>http://www.medworm.com/index.php?rid=5669352&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmeghancasserly%2F2012%2F02%2F03%2Fsusan-g-komen-caves-reinstates-planned-parenthood-funding%2F</link>
            <description>The&amp;nbsp;Susan G. Komen foundation released a statement this morning renouncing its highly contested decision to discontinue its funding to women’s health provider Planned Parenthood. The announcement this Tuesday caused the web—and the women’s space—to erupt in anger and disbelief over whether the nation’s most prominent breast cancer charity put politics before the well-being of under privileged women. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669352</comments>
            <pubDate>Fri, 03 Feb 2012 17:06:57 +0100</pubDate>
            <guid isPermaLink="false">5669352</guid>        </item>
        <item>
            <title>Reauthorize PDUFA!</title>
            <link>http://www.medworm.com/index.php?rid=5661316&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdougschoen%2F2012%2F02%2F03%2Freauthorize-pdufa%2F</link>
            <description>Congress’ House Energy and Commerce Health Subcommittee held a hearing yesterday on the reauthorization of the FDA’s Prescription Drug User Fee Act (PDUFA), which is set to expire later this year.&amp;nbsp; This is critically important legislation that needs to be renewed to have a safe and plentiful drug supply for American consumers at affordable prices. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661316</comments>
            <pubDate>Fri, 03 Feb 2012 17:02:48 +0100</pubDate>
            <guid isPermaLink="false">5661316</guid>        </item>
        <item>
            <title>The ACA and the Power of the Breast Lobby</title>
            <link>http://www.medworm.com/index.php?rid=5661317&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarolynmcclanahan%2F2012%2F02%2F03%2Fthe-aca-and-the-power-of-the-breast-lobby%2F</link>
            <description>Breast cancer is a devastating illness that strikes down wonderful women in their prime through no fault of their own.&amp;nbsp; We lose our mothers, friends, and sisters after watching them go through agonizing treatments.&amp;nbsp; I have worked with cancer patients and have been with many dying people, yet it did not prepare me for the senseless death of my college roommate from breast cancer at the age of 42, leaving behind her husband and three beautiful young children.&amp;nbsp; It is very emotional. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661317</comments>
            <pubDate>Fri, 03 Feb 2012 16:04:51 +0100</pubDate>
            <guid isPermaLink="false">5661317</guid>        </item>
        <item>
            <title>Health Insurance Stocks For a Republican Win</title>
            <link>http://www.medworm.com/index.php?rid=5661318&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fthestreet%2F2012%2F02%2F03%2Fhealth-insurance-stocks-for-a-republican-win%2F</link>
            <description>Investors busy assessing how the state of the global economy will affect their stock portfolios should start thinking about how the presidential race will weigh in.&amp;nbsp;
In particular, investors may want to look at how to play the health insurance space.&amp;nbsp;
Health care remains a subject of divide between the two parties, with Republicans trying to repeal Obama's nationwide health care reform since 2010. And, while it is unlikely they can overturn the entire law, they can certainly chip away at parts of it.&amp;nbsp;
Related Links (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661318</comments>
            <pubDate>Fri, 03 Feb 2012 12:16:03 +0100</pubDate>
            <guid isPermaLink="false">5661318</guid>        </item>
        <item>
            <title>Do something really innovative in health: crowdsource problems, not (just) solutions</title>
            <link>http://www.medworm.com/index.php?rid=5651411&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidshaywitz%2F2012%2F02%2F03%2Fdo-something-really-innovative-in-health-crowdsource-problems-not-just-solutions%2F</link>
            <description>Businesses exist to solve problems, right?&amp;nbsp; Certainly, this is the heart of the classic entrepreneurial model: you become obsessed with a particular problem, and create a business to solve it.&amp;nbsp; Example: eBay was created by Pierre Omidyar to solve a perceived problem with inefficient markets, and since its inception has generally focused on doing exactly this. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651411</comments>
            <pubDate>Fri, 03 Feb 2012 06:01:38 +0100</pubDate>
            <guid isPermaLink="false">5651411</guid>        </item>
        <item>
            <title>CMS Releases Details Of Proposed National Coverage For TAVR</title>
            <link>http://www.medworm.com/index.php?rid=5651412&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F02%2F02%2Fcms-releases-details-of-proposed-national-coverage-for-tavr%2F</link>
            <description>On Thursday the Centers for Medicare &amp; Medicaid Services (CMS) released a memo containing details of its proposed Medicare coverage for TAVR (transcatheter aortic valve replacement). The memo is a response to a formal request for&amp;nbsp;national coverage determination (NCD) from the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC).&amp;nbsp;The memo will be open for public comment until March 3, after which a final determination will be made. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651412</comments>
            <pubDate>Fri, 03 Feb 2012 02:46:39 +0100</pubDate>
            <guid isPermaLink="false">5651412</guid>        </item>
        <item>
            <title>The Truth About Contraception, Obamacare And The Church</title>
            <link>http://www.medworm.com/index.php?rid=5651413&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Frickungar%2F2012%2F02%2F02%2Fthe-truth-about-contraception-obamacare-and-the-church%2F</link>
            <description>&amp;nbsp; &amp;nbsp; Image by AFP/Getty Images via @daylife Much has been misunderstood about what the Affordable Care Act requires when it comes to religious institutions and contraception. Recently, the Catholic Church lashed out at the Obama Administration, including HSS Secretary Kathleen Sebelius, for handing down regulations that fail to exempt certain operations of the (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651413</comments>
            <pubDate>Fri, 03 Feb 2012 01:45:58 +0100</pubDate>
            <guid isPermaLink="false">5651413</guid>        </item>
        <item>
            <title>Can Greenway Medical Keep Up The Momentum After Its IPO?</title>
            <link>http://www.medworm.com/index.php?rid=5651414&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fzinamoukheiber%2F2012%2F02%2F02%2Fcan-greenway-medical-keep-up-the-momentum-after-its-ipo%2F</link>
            <description>Greenway Medical Technologies, a seller of electronic health records, got off to a bumpy start when its bankers re-priced last minute its IPO downward to $10 a share from an original range of $11 to $13 a share. It closed today at $13, up 30%--valuing it at three times revenue, in line with competitors such as NextGen.&amp;nbsp; (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651414</comments>
            <pubDate>Fri, 03 Feb 2012 00:54:45 +0100</pubDate>
            <guid isPermaLink="false">5651414</guid>        </item>
        <item>
            <title>Study Explores Role of Periprocedural Dabigatran in AF Ablation</title>
            <link>http://www.medworm.com/index.php?rid=5651415&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F02%2F02%2Fstudy-explores-role-of-periprocedural-dabigatran-in-af-ablation%2F</link>
            <description>Updated with a comment from John Mandrola-- As dabigatran becomes more widely used in atrial fibrillation (AF) patients, electrophysiologists are now trying to figure out how to handle anticoagulation in patients taking dabigatran (Pradaxa) for whom AF ablation is planned. In&amp;nbsp;a new study published in the Journal of the American College of Cardiology,&amp;nbsp;Dhanunjaya Lakkireddy and colleagues report on a multicenter, observational study of 290 patients who underwent an AF ablation procedure. Half the patients were taking periprocedural dabigatran and half were matched controls taking warfarin. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651415</comments>
            <pubDate>Thu, 02 Feb 2012 20:29:26 +0100</pubDate>
            <guid isPermaLink="false">5651415</guid>        </item>
        <item>
            <title>The Supreme Court ruling: what's at stake for health care?</title>
            <link>http://www.medworm.com/index.php?rid=5651416&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdougschoen%2F2012%2F02%2F02%2Fthe-supreme-court-ruling-whats-at-stake-for-health-care%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651416</comments>
            <pubDate>Thu, 02 Feb 2012 16:21:03 +0100</pubDate>
            <guid isPermaLink="false">5651416</guid>        </item>
        <item>
            <title>More Evidence That Honey Can Treat Antibiotic Resistant Infections</title>
            <link>http://www.medworm.com/index.php?rid=5651417&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Falexknapp%2F2012%2F02%2F02%2Fmore-evidence-that-honey-can-treat-antibiotic-resistant-infections%2F</link>
            <description>One of the more fascinating ways that medical researchers are looking in to fighting antibiotic resistant bacteria is through the use of Manuka honey. Last year, some research was published evidencing some effectiveness against MRSA. Now a team from the&amp;nbsp;Cardiff School of Health&amp;nbsp;Sciences has demonstrated the effectiveness of this honey against&amp;nbsp;Streptococcus pyogenes, an antibiotic resistant bacteria that often infects wounds and can prevent skin grafts from forming. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651417</comments>
            <pubDate>Thu, 02 Feb 2012 16:07:18 +0100</pubDate>
            <guid isPermaLink="false">5651417</guid>        </item>
        <item>
            <title>Repealing the CLASS Act</title>
            <link>http://www.medworm.com/index.php?rid=5651418&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F02%2F01%2Frepealing-the-class-act%2F</link>
            <description>The first part of the health reform law to fall was not struck down by the Supreme Court, blocked by state governments, or defunded by Congress &amp;ndash; it was struck down by the Obama Administration itself, which stated that the program could not be implemented as passed, and therefore would simply be ignored. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651418</comments>
            <pubDate>Thu, 02 Feb 2012 00:14:16 +0100</pubDate>
            <guid isPermaLink="false">5651418</guid>        </item>
        <item>
            <title>Dendreon Names A New CEO, But Will It Be Enough?</title>
            <link>http://www.medworm.com/index.php?rid=5651419&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fedsilverman%2F2012%2F02%2F01%2Fdendreon-names-a-new-ceo-but-will-it-be-enough%2F</link>
            <description>After a year filled with setbacks and mounting investor anger,&amp;nbsp;Dendreon has replaced Mitchell Gold as ceo with John Johnson, a recently appointed Dendreon board member who has a&amp;nbsp;long track record of working in oncology for big pharma - notably, Eli Lilly and Johnson &amp; Johnson. The move signals a belated recognition that the embattled company needs more experienced management if its&amp;nbsp;Provenge vaccine for prostate cancer is to become a blockbuster. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651419</comments>
            <pubDate>Wed, 01 Feb 2012 19:02:11 +0100</pubDate>
            <guid isPermaLink="false">5651419</guid>        </item>
        <item>
            <title>Meta-Analysis Confirms Benefits Of Statins In Women</title>
            <link>http://www.medworm.com/index.php?rid=5651420&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F02%2F01%2Fmeta-analysis-confirms-benefits-of-statins-in-women%2F</link>
            <description>Although clinical trials have consistently found a beneficial effects for statins, some critics have questioned the strength of the evidence in women, who are often under-represented in clinical trials. &amp;nbsp;A large new meta-analysis published in the Journal of the American College of Cardiology provides the best evidence yet that the relative reductions in events observed in men also occur in women, but doesn't provide evidence about the absolute risk benefit in women. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651420</comments>
            <pubDate>Wed, 01 Feb 2012 17:59:12 +0100</pubDate>
            <guid isPermaLink="false">5651420</guid>        </item>
        <item>
            <title>Susan G. Komen Pink Slips Planned Parenthood -- Who, What And Why?</title>
            <link>http://www.medworm.com/index.php?rid=5661319&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmeghancasserly%2F2012%2F02%2F01%2Fsusan-g-komen-pink-slips-planned-parenthood-who-what-and-why%2F</link>
            <description>Tuesday’s announcement that brand name breast cancer charity Susan G. Komen for the Cure would put an end to its long time partnership with women’s health resource Planned Parenthood nearly broke the Internet. Twitter faltered—then erupted in vitriol against the purveyors of pink. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661319</comments>
            <pubDate>Wed, 01 Feb 2012 17:56:34 +0100</pubDate>
            <guid isPermaLink="false">5661319</guid>        </item>
        <item>
            <title>Why CEO Replacement Is Good News For Dendreon</title>
            <link>http://www.medworm.com/index.php?rid=5661320&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F02%2F01%2Fwhy-ceo-replacement-is-good-news-for-dendreon%2F</link>
            <description>The news that Dendreon is under new management should cheer investors and help lay the groundwork for figuring out how to best sell the company's groundbreaking prostate cancer treatment, Provenge, which aims to harness the immune system to fight tumors. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661320</comments>
            <pubDate>Wed, 01 Feb 2012 13:34:59 +0100</pubDate>
            <guid isPermaLink="false">5661320</guid>        </item>
        <item>
            <title>If Self-Injury Is So Prevalent, Why Do We Know So Little About It?</title>
            <link>http://www.medworm.com/index.php?rid=5651421&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Falicegwalton%2F2012%2F01%2F31%2Fif-self-injury-is-so-prevalent-why-do-we-know-so-little-about-it%2F</link>
            <description>Acts of self-injury like cutting have become behaviors of which most people are at least generally aware. Cutting is discussed solemnly on news and talk shows, often as a phenomenon of disturbed teens, or worse, of attention-seekers. But there’s much more involved in the range of behaviors than just that, and self-injury is not a new phenomenon. It’s been studied somewhat more extensively in recent years, although it’s not particularly high on the medical profession’s list of priorities. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651421</comments>
            <pubDate>Wed, 01 Feb 2012 04:10:04 +0100</pubDate>
            <guid isPermaLink="false">5651421</guid>        </item>
        <item>
            <title>WellPoint Bets (A Bit) On Primary Care</title>
            <link>http://www.medworm.com/index.php?rid=5651422&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidwhelan%2F2012%2F01%2F31%2Fwellpoint-bets-a-bit-on-primary-care%2F</link>
            <description>A news article on the front page of Friday’s Wall Street Journal described how WellPoint, the nation’s second largest insurer, will begin paying extra bonuses to primary care doctors in its network. These bonuses will add $100,000 in revenue for participating physicians. WellPoint, which runs Blue Cross and Blue Shield plans in 14 states, says that the change is needed because the health system devalues internists and family doctors. A chart accompanying the article compares median salaries of primary care doctors ($200,000) to specialists like orthopedists ($500,000), and urologists ($375,000). (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651422</comments>
            <pubDate>Tue, 31 Jan 2012 22:10:15 +0100</pubDate>
            <guid isPermaLink="false">5651422</guid>        </item>
        <item>
            <title>United we stand: the new approach in fighting neglected tropical diseases (NTDs)</title>
            <link>http://www.medworm.com/index.php?rid=5651423&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fsarikabansal%2F2012%2F01%2F31%2Funited-we-stand-a-new-mentality-in-the-fight-against-neglected-tropical-diseases-ntds%2F</link>
            <description>Yesterday was a huge day for the neglected tropical disease (NTD) community. A consortium of organizations – including 13 pharmaceutical companies, the US, UK, and UAE governments, the Bill &amp; Melinda Gates Foundation, the World Bank, the World Health Organization, and more – announced in London the largest coordinated push in the history of fighting NTDs. Combined, they will research, develop, donate, and distribute billions of drugs, with the hope of ending or controlling the ten most prevalent neglected diseases by 2020. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651423</comments>
            <pubDate>Tue, 31 Jan 2012 21:34:10 +0100</pubDate>
            <guid isPermaLink="false">5651423</guid>        </item>
        <item>
            <title>Consensus Document Provides Roadmap To Uptake Of TAVR In US</title>
            <link>http://www.medworm.com/index.php?rid=5651424&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F31%2Fconsensus-document-provides-roadmap-to-uptake-of-tavr-in-us%2F</link>
            <description>Following the recent approval by the FDA of&amp;nbsp;transcatheter aortic valve replacement (TAVR), the ACC, AATS, SCAI, and STS, in conjunction with several other medical organizations, have released a critical consensus document to guide use of the new landmark procedure. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651424</comments>
            <pubDate>Tue, 31 Jan 2012 19:21:53 +0100</pubDate>
            <guid isPermaLink="false">5651424</guid>        </item>
        <item>
            <title>A Look Back at Year One of The Apothecary at Forbes</title>
            <link>http://www.medworm.com/index.php?rid=5651425&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F31%2Fa-look-back-at-year-one-of-the-apothecary-at-forbes%2F</link>
            <description>One year ago, I moved my little health-care blog from avikroy.org over to Forbes.com. And what a year it’s been. There has been no shortage of things to write about—and thanks to the paramount importance of entitlement reform and health policy, that will continue to be true for the foreseeable future. So I wanted to take the chance to reflect on The Apothecary’s year that was. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651425</comments>
            <pubDate>Tue, 31 Jan 2012 17:22:00 +0100</pubDate>
            <guid isPermaLink="false">5651425</guid>        </item>
        <item>
            <title>How to fix Medicare, Redux</title>
            <link>http://www.medworm.com/index.php?rid=5651426&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdougschoen%2F2012%2F01%2F31%2Fhow-to-fix-medicare-redux%2F</link>
            <description>The Republican Presidential primary’s shift down south to Florida has brought discussions of healthcare, particularly Medicare, back to the forefront of the national discourse.&amp;nbsp; With its struggling economy and sizeable elderly population, social welfare programs like Medicare, Medicaid and Social Security are top of mind to Florida voters. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651426</comments>
            <pubDate>Tue, 31 Jan 2012 15:39:24 +0100</pubDate>
            <guid isPermaLink="false">5651426</guid>        </item>
        <item>
            <title>Taxes and the ACA:  Home Sales Killer?</title>
            <link>http://www.medworm.com/index.php?rid=5651427&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarolynmcclanahan%2F2012%2F01%2F31%2Ftaxes-and-the-aca-home-sales-killer%2F</link>
            <description>One goal of my “Quest for Simplicity” is to explain the ACA in terms we can all understand, so we can decide what parts of the law we should keep and what we should change. &amp;nbsp;In previous articles, I have discussed the costs and complexity of our current insurance and medical care financing. &amp;nbsp;Basically, our lawmakers decided to build upon this ineffective system when they could have cleaned it up, simplified, improved efficiency, and cut costs. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651427</comments>
            <pubDate>Tue, 31 Jan 2012 13:47:17 +0100</pubDate>
            <guid isPermaLink="false">5651427</guid>        </item>
        <item>
            <title>Futures Rise on EU Budget Pact; Pfizer and Exxon Mobil Earnings in Focus</title>
            <link>http://www.medworm.com/index.php?rid=5651428&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fjosephhargett%2F2012%2F01%2F31%2Ffutures-rise-on-eu-budget-pact-pfizer-and-exxon-mobil-earnings-in-focus%2F</link>
            <description>The Dow Jones industrial Average (DJIA) headed for a positive open this morning, as Wall Street cheers a euro-zone pact for tougher budget rules and progress on Greece's debt issues. Heading into the open, U.S. stock futures on the Dow Mini are trading about 53 points above fair value, while S&amp;P 500 Index (SPX) futures are 5.5 points above fair value. Nasdaq Mini (NDX) futures are indicating a gain of about 8.4 points on the open. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651428</comments>
            <pubDate>Tue, 31 Jan 2012 13:24:58 +0100</pubDate>
            <guid isPermaLink="false">5651428</guid>        </item>
        <item>
            <title>Healthcare's Medical Gluttony</title>
            <link>http://www.medworm.com/index.php?rid=5651429&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdanmunro%2F2012%2F01%2F31%2Fhealthcares-medical-gluttony%2F</link>
            <description>Seems to me we always have a few big breaking healthcare stories early in the year. &amp;nbsp;I remember last year when Mary Meeker released her stunning report - USA, Inc. &amp;nbsp;For the first time, it gave us a detailed view into the health of our country - as if it were a Corporation using balance sheet accounting. &amp;nbsp;That report is truly outstanding. &amp;nbsp;If you haven't read it - I can't recommend it highly enough. &amp;nbsp;In some ways I think it's &quot;table stakes&quot; for any intelligent discussion around the health (and healthcare) of our Country. In that report are two charts that graphically illustrate the size of our healthcare spending (as reported through 2009) - and then the results of our healthcare system. &amp;nbsp;This was the first one: (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651429</comments>
            <pubDate>Tue, 31 Jan 2012 05:57:45 +0100</pubDate>
            <guid isPermaLink="false">5651429</guid>        </item>
        <item>
            <title>Visual Trick of the Day: Stare at the Red Nosed Lady</title>
            <link>http://www.medworm.com/index.php?rid=5651430&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdaviddisalvo%2F2012%2F01%2F30%2Fvisual-trick-of-the-day-stare-at-the-red-nosed-lady%2F</link>
            <description>I'm not sure where this originated (if you know please tell me), but it is&amp;nbsp;absolutely&amp;nbsp;fascinating. &amp;nbsp;Stare at this lady's red nose for 30 seconds and then look at a wall while blinking very quickly. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651430</comments>
            <pubDate>Tue, 31 Jan 2012 03:14:35 +0100</pubDate>
            <guid isPermaLink="false">5651430</guid>        </item>
        <item>
            <title>Bulls Bet On Office Depot, Pfizer Options In Play Before Earnings</title>
            <link>http://www.medworm.com/index.php?rid=5651431&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fgreatspeculations%2F2012%2F01%2F30%2Fbulls-bet-on-office-depot-pfizer-options-in-play-before-earnings%2F</link>
            <description>Today’s tickers: PFE, ODP &amp; MRX (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651431</comments>
            <pubDate>Mon, 30 Jan 2012 22:30:42 +0100</pubDate>
            <guid isPermaLink="false">5651431</guid>        </item>
        <item>
            <title>Appropriate Use Criteria for Revascularization Updated</title>
            <link>http://www.medworm.com/index.php?rid=5651432&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F30%2Fappropriate-use-criteria-for-revascularization-updated%2F</link>
            <description>The ACC, AHA, and other organizations have released updated appropriate use criterial for coronary revascularization. The&amp;nbsp;2012 Appropriate Use Criteria for Coronary Revascularization Focused Update incorporates data from the SYNTAX trial on the indications for PCI and CABG in patients with symptomatic, multivessel disease, as well as data from the CathPCI registry. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651432</comments>
            <pubDate>Mon, 30 Jan 2012 21:11:51 +0100</pubDate>
            <guid isPermaLink="false">5651432</guid>        </item>
        <item>
            <title>Very Large Observational Study Finds Significant Mortality Advantage for CABG Over PCI in High Risk Patients</title>
            <link>http://www.medworm.com/index.php?rid=5651433&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F30%2Fvery-large-observational-study-finds-significant-mortality-advantage-for-cabg-over-pci-in-high-risk-patients%2F</link>
            <description>Although PCI has a small, early mortality benefit compared to CABG in high risk patients, after the first year a striking survival advantage for CABG develops, according to results of the ASCERT study, presented on Monday at the annual meeting of the Society of Thoracic Surgeons (STS) meeting. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651433</comments>
            <pubDate>Mon, 30 Jan 2012 19:18:03 +0100</pubDate>
            <guid isPermaLink="false">5651433</guid>        </item>
        <item>
            <title>What the Roche Bid for Illumina Tells Us About the Future of Genomics</title>
            <link>http://www.medworm.com/index.php?rid=5651434&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F30%2Fwhat-the-roche-bid-for-illumina-tells-us-about-the-future-of-genomics%2F</link>
            <description>There’s been a flurry of mergers in the pharmaceutical and biotechnology industries lately. My Manhattan Institute colleague Paul Howard has some thoughts on one of the more interesting potential transactions: the hostile bid for Illumina, a genetic diagnostics company, by Swiss pharmaceutical giant Roche.
Roche already has a diagnostics division, so they don't need the acquisition to help drive any of their targeted medicines. After all, once you know the &quot;target&quot; for a personalized cancer drug (like Herceptin) and get it on the FDA-approved label you don't need to know anything else about your patient's genome. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651434</comments>
            <pubDate>Mon, 30 Jan 2012 17:18:37 +0100</pubDate>
            <guid isPermaLink="false">5651434</guid>        </item>
        <item>
            <title>Super Bowl Sanitation: &quot;Washed Up&quot; Giants Outpoint Docs</title>
            <link>http://www.medworm.com/index.php?rid=5651435&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmichaelmillenson%2F2012%2F01%2F30%2Fsuper-bowl-sanitation-washed-up-giants-outpoint-docs%2F</link>
            <description>Is the New York Giants bathroom more sanitary than your hospital room? Could be. And that player cleanliness may even have helped send the team to the Super Bowl. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651435</comments>
            <pubDate>Mon, 30 Jan 2012 16:17:10 +0100</pubDate>
            <guid isPermaLink="false">5651435</guid>        </item>
        <item>
            <title>The Keys to Professional Success Today: Bureeda Bruner's Story</title>
            <link>http://www.medworm.com/index.php?rid=5651436&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fshawnoconnor%2F2012%2F01%2F30%2Fthe-keys-to-professional-success-today-bureeda-bruners-story%2F</link>
            <description>The so-called “Great Recession” has caused tremendous despair among employees and job-seekers alike, who have justifiably felt disillusioned and frustrated. Many younger and older Americans, who never thought they would need government assistance, are now living off unemployment insurance. In fact, while we’ve seen some improvement in the unemployment rate, there are still more than 5 million people without jobs. Given these trying circumstances, it is easy to lose hope and question whether one will ever again enjoy compelling professional opportunities; this is especially true for those with little, if any, post-secondary education. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651436</comments>
            <pubDate>Mon, 30 Jan 2012 15:39:05 +0100</pubDate>
            <guid isPermaLink="false">5651436</guid>        </item>
        <item>
            <title>The Non-Viable CLASS Act</title>
            <link>http://www.medworm.com/index.php?rid=5651437&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F30%2Fthe-non-viable-class-act%2F</link>
            <description>One of Sen. Ted Kennedy's long-standing goals was the establishment of a federal program for long-term care for the infirm and disabled. This goal was &amp;ndash; apparently &amp;ndash; achieved posthumously when his Community Living Assistance Services and Supports (CLASS) Act was incorporated into the Patient Protection and Affordable Care Act (PPACA). (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651437</comments>
            <pubDate>Mon, 30 Jan 2012 15:00:49 +0100</pubDate>
            <guid isPermaLink="false">5651437</guid>        </item>
        <item>
            <title>10 Often-Missed Signs of Heart Attack in Women - Via A Viral Video</title>
            <link>http://www.medworm.com/index.php?rid=5651438&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmelaniehaiken%2F2012%2F01%2F30%2F10-often-overlooked-signs-of-heart-attack-in-women-the-amas-viral-video-gets-it-right%2F</link>
            <description>Making the viral rounds of Facebook, Twitter, Email, and good old non-virtual word of mouth is &quot;Just a Little Heart Attack&quot; - a hilarious video produced for the American Heart Association (AHA) showing a typical overworked, stressed out modern super mom having a heart attack while trying to to cope with the pressures of work and motherhood. The video, a cornerstone of the AHA's new Go Red for Women campaign, does a great service in highlighting how different heart attack symptoms may appear in women and how often women ignore them because they're not the traditional signs always depicted in movies and warning materials. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651438</comments>
            <pubDate>Mon, 30 Jan 2012 10:52:11 +0100</pubDate>
            <guid isPermaLink="false">5651438</guid>        </item>
        <item>
            <title>Craigslist's Approach To Health Care Means Baby Formula, Experimental Drugs and Kidneys For Sale</title>
            <link>http://www.medworm.com/index.php?rid=5651439&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidwhelan%2F2012%2F01%2F30%2Fcraigslist-does-health-care-with-baby-formula-experimental-drugs-and-kidneys-for-sale%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651439</comments>
            <pubDate>Mon, 30 Jan 2012 07:05:51 +0100</pubDate>
            <guid isPermaLink="false">5651439</guid>        </item>
        <item>
            <title>Craigslist Does Health Care With Baby Formula, Experimental Drugs and Kidneys For Sale</title>
            <link>http://www.medworm.com/index.php?rid=5639942&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidwhelan%2F2012%2F01%2F30%2Fcraigslist-does-health-care-with-baby-formula-experimental-drugs-and-kidneys-for-sale%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639942</comments>
            <pubDate>Mon, 30 Jan 2012 07:05:51 +0100</pubDate>
            <guid isPermaLink="false">5639942</guid>        </item>
        <item>
            <title>Supreme Court Rules Americans Can Eat Sick Pigs, Cows</title>
            <link>http://www.medworm.com/index.php?rid=5639943&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmichellemaisto%2F2012%2F01%2F28%2Fcongress-rules-americans-can-eat-sick-pigs-cows%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639943</comments>
            <pubDate>Sat, 28 Jan 2012 16:16:48 +0100</pubDate>
            <guid isPermaLink="false">5639943</guid>        </item>
        <item>
            <title>Hooking Up With Gen Y - Challenge for Business</title>
            <link>http://www.medworm.com/index.php?rid=5639944&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fpeterjreilly%2F2012%2F01%2F27%2Fhooking-up-with-gen-y-challenge-for-business%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639944</comments>
            <pubDate>Sat, 28 Jan 2012 01:20:53 +0100</pubDate>
            <guid isPermaLink="false">5639944</guid>        </item>
        <item>
            <title>And They're Off: Amylin And Novo Nordisk Begin Their Battle</title>
            <link>http://www.medworm.com/index.php?rid=5639945&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fedsilverman%2F2012%2F01%2F27%2Fand-theyre-off-amylin-and-novo-nordisk-begin-their-battle%2F</link>
            <description>Nearly two years after the FDA issued what became the first of two rejections, the agency has finally approved the Bydureon diabetes treatment, setting up what is going to be heated battle between Amylin Pharmaceuticals and Novo Nordisk, which sells a rival medicine called Victoza. Both drugs are part of the GLP-1 class of diabetes medications (here is the approval letter). (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639945</comments>
            <pubDate>Fri, 27 Jan 2012 22:37:54 +0100</pubDate>
            <guid isPermaLink="false">5639945</guid>        </item>
        <item>
            <title>Could the PPACA's Medicaid Expansion be Unconstitutional?</title>
            <link>http://www.medworm.com/index.php?rid=5639946&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F27%2Fcould-the-ppacas-medicaid-expansion-be-unconstitutional%2F</link>
            <description>While most of the public debate on the constitutionality of the health reform law has centered on the “individual mandate” – the requirement to obtain government-approved health insurance or pay a penalty – the Supreme Court has also agreed to consider another, far less discussed issue: whether the law's expansion of Medicaid eligibility might be an unconstitutional federal infringement on state legislative authority. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639946</comments>
            <pubDate>Fri, 27 Jan 2012 20:54:03 +0100</pubDate>
            <guid isPermaLink="false">5639946</guid>        </item>
        <item>
            <title>What Happens After CLASS?</title>
            <link>http://www.medworm.com/index.php?rid=5639947&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fhowardgleckman%2F2012%2F01%2F27%2Fwhat-happens-after-class%2F</link>
            <description>My best guess is that Congress will formally repeal the CLASS Act in 2012. Already abandoned by the Obama Administration, CLASS has no champion on Capitol Hill and is likely to fall victim to implacable Republican opposition and a lack of Democratic support. Thanks to technical budget rules, Congress can now kill the national, voluntary long-term care insurance program without adding to the deficit. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639947</comments>
            <pubDate>Fri, 27 Jan 2012 20:05:20 +0100</pubDate>
            <guid isPermaLink="false">5639947</guid>        </item>
        <item>
            <title>Spending Other People's Money: What Professors And Doctors Have In Common</title>
            <link>http://www.medworm.com/index.php?rid=5639948&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidwhelan%2F2012%2F01%2F27%2Fspending-other-peoples-money-what-professors-and-doctors-have-in-common%2F</link>
            <description>Consider these two common scenarios:
SCENARIO A
 
You go to the doctor's office and get a prescription. Late the pharmacist runs it through her computer and&amp;nbsp;against your&amp;nbsp;insurance--and hands you the bill.&amp;nbsp;If it's&amp;nbsp;a brand-name med&amp;nbsp;get ready for the&amp;nbsp;sticker shock. I've had to pay $10 per pill, out of pocket,&amp;nbsp;when I've been under my deductible. I know another patient&amp;nbsp;who&amp;nbsp;had&amp;nbsp;a $300 course of eye drops&amp;nbsp;prescribed when a $25 alternative existed--and&amp;nbsp;his doctor had no idea.
SCENARIO B
You go to class and pick up your syllabus for the semester. At the college bookstore you pick up one of the books that's been assigned. Again: sticker shock ensues.&amp;nbsp;I recently was assigned this flimsy, out-of-date&amp;nbsp;paperback for one of my cla...</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639948</comments>
            <pubDate>Fri, 27 Jan 2012 19:10:10 +0100</pubDate>
            <guid isPermaLink="false">5639948</guid>        </item>
        <item>
            <title>ACC 2012 Roster of Late-Breaking Clinical Trials</title>
            <link>http://www.medworm.com/index.php?rid=5639949&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F27%2Facc-2012-roster-of-late-breaking-clinical-trials%2F</link>
            <description>The American College of Cardiology has released the roster of late-breaking clinical trials that will be presented in March at the ACC Scientific Sessions: (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639949</comments>
            <pubDate>Fri, 27 Jan 2012 19:04:00 +0100</pubDate>
            <guid isPermaLink="false">5639949</guid>        </item>
        <item>
            <title>New Medical Tourism Hub Being Built in Abu Dhabi</title>
            <link>http://www.medworm.com/index.php?rid=5639950&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fforbestravelguide%2F2012%2F01%2F27%2Fnew-medical-tourism-hub-being-built-in-abu-dhabi%2F</link>
            <description>When Rosewood Hotels and Resorts opens its new high-rise in Abu Dhabi at the end of this year, it will have a valuable next-door neighbor: the Cleveland Clinic. Both the Ohio-based medical center and the hotel group are newcomers to the United Arab Emirates, a new hub for the medical world. For the clinic, the move is even more of a milestone—the Abu Dhabi location is the Cleveland Clinic’s first outside North America (other branches include Palm Beach, Las Vegas and Toronto). (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639950</comments>
            <pubDate>Fri, 27 Jan 2012 18:25:41 +0100</pubDate>
            <guid isPermaLink="false">5639950</guid>        </item>
        <item>
            <title>Road Not Taken: The Unrecognized Harm of Excessive Regulation</title>
            <link>http://www.medworm.com/index.php?rid=5639951&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidshaywitz%2F2012%2F01%2F27%2Fcare-about-new-medicines-watch-this-video%2F</link>
            <description>The difficulty of creating new and better medicines has been the subject of extensive – at times excessive – soul searching, a process that’s intensified as high-profile patents expire, along with their associated revenue streams, traditionally&amp;nbsp;relied upon&amp;nbsp;to support future R&amp;D.&amp;nbsp; As a result, both biopharma companies and patients awaiting new treatments find themselves struggling for viable solutions.&amp;nbsp; (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639951</comments>
            <pubDate>Fri, 27 Jan 2012 18:23:49 +0100</pubDate>
            <guid isPermaLink="false">5639951</guid>        </item>
        <item>
            <title>GE, 3M Get Richer As The World Gets Older</title>
            <link>http://www.medworm.com/index.php?rid=5639952&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fgreatspeculations%2F2012%2F01%2F27%2Fge-3m-get-richer-as-the-world-gets-older%2F</link>
            <description>One of the investing strategies championed by legendary investor and Acorn Fund manager Ralph Wanger is to identify companies (typically smaller) which would benefit from a macro trend and then buy into those companies for the long-term while the trend plays out. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639952</comments>
            <pubDate>Fri, 27 Jan 2012 17:56:11 +0100</pubDate>
            <guid isPermaLink="false">5639952</guid>        </item>
        <item>
            <title>Demand for Therapy Jobs Critically High in 2012</title>
            <link>http://www.medworm.com/index.php?rid=5639953&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmoneywisewomen%2F2012%2F01%2F27%2Fdemand-for-therapy-jobs-critically-high-in-2012%2F</link>
            <description>Rehabilitation therapy is a diverse field within the healthcare industry. It includes both occupational and physical therapy. Occupational therapists work primarily with senior citizens, evaluating and improving their abilities related to physical maladies. While physical therapy is in close relation to occupational therapy, a physical therapist works more with treating specific injuries and diagnosing physical problems. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639953</comments>
            <pubDate>Fri, 27 Jan 2012 15:27:20 +0100</pubDate>
            <guid isPermaLink="false">5639953</guid>        </item>
        <item>
            <title>Bears Barge Into Deutsche Bank Put Options</title>
            <link>http://www.medworm.com/index.php?rid=5631112&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fgreatspeculations%2F2012%2F01%2F26%2Fbears-barge-into-deutsche-bank-put-options%2F</link>
            <description>Today’s tickers: DB, ATHN &amp; LSI (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631112</comments>
            <pubDate>Thu, 26 Jan 2012 19:15:23 +0100</pubDate>
            <guid isPermaLink="false">5631112</guid>        </item>
        <item>
            <title>NHLBI Launches Two Large Cardiac Arrest Treatment Trials</title>
            <link>http://www.medworm.com/index.php?rid=5631113&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F26%2Fnhlbi-launches-two-large-cardiac-arrest-treatment-trials%2F</link>
            <description>The NHLBI today announced the launch of two large clinical trials evaluating treatments for out-of-hospital cardiac arrest. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631113</comments>
            <pubDate>Thu, 26 Jan 2012 17:22:29 +0100</pubDate>
            <guid isPermaLink="false">5631113</guid>        </item>
        <item>
            <title>Why You Might Want Your Next Medical Exam Via Computer</title>
            <link>http://www.medworm.com/index.php?rid=5639954&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F26%2Fwhy-you-might-want-your-next-medical-exam-via-computer%2F</link>
            <description>&amp;nbsp; (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639954</comments>
            <pubDate>Thu, 26 Jan 2012 16:17:53 +0100</pubDate>
            <guid isPermaLink="false">5639954</guid>        </item>
        <item>
            <title>Big Drop in Incidence and Fatality of MIs in England</title>
            <link>http://www.medworm.com/index.php?rid=5631114&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F26%2Fbig-drop-in-incidence-and-fatality-of-mis-in-england%2F</link>
            <description>Since 2002 in England the incidence of acute MI has dropped by one-half and the case fatality rate by one-third, according to a new study published in BMJ. The overall decline in deaths from MI are about equally due to improvements in the prevention of MI and the treatment of MI. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631114</comments>
            <pubDate>Thu, 26 Jan 2012 16:17:13 +0100</pubDate>
            <guid isPermaLink="false">5631114</guid>        </item>
        <item>
            <title>Combativeness Doesn't Equal Seriousness about Entitlement Reform</title>
            <link>http://www.medworm.com/index.php?rid=5631115&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F25%2Fcombativeness-doesnt-equal-seriousness-about-entitlement-reform%2F</link>
            <description>Last week, I wrote about the curious phenomenon of right-wing populists who say that they’re the true believers in limited government, while opposing the candidates who actually make substantive proposals to that end. Dan McLaughlin of Redstate.com has put forth a rebuttal that helps illuminate the problem. Dan incorrectly surmises that I “equate having position papers with being serious about reform,” when he in fact makes the opposite mistake, by equating a combative personality with being serious about reform. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631115</comments>
            <pubDate>Thu, 26 Jan 2012 04:17:11 +0100</pubDate>
            <guid isPermaLink="false">5631115</guid>        </item>
        <item>
            <title>What Are The Costs And Benefits of Patents for Prescription Drugs?</title>
            <link>http://www.medworm.com/index.php?rid=5631116&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F25%2Fwhat-are-the-costs-and-benefits-of-patents-for-prescription-drugs%2F</link>
            <description>By John R. Graham, CAIA (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631116</comments>
            <pubDate>Thu, 26 Jan 2012 00:30:02 +0100</pubDate>
            <guid isPermaLink="false">5631116</guid>        </item>
        <item>
            <title>Huge Study Finds Risk Factors Do In Fact Predict Risk</title>
            <link>http://www.medworm.com/index.php?rid=5631117&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F25%2Fhuge-study-finds-risk-factors-do-in-fact-predict-risk%2F</link>
            <description>An enormous new meta-analysis confirms the important role that risk factors play over a lifetime in the development of cardiovascular disease.&amp;nbsp;In a paper&amp;nbsp;published in the New England Journal of Medicine, Jarett Berry and colleagues report on the new meta-analysis from the Cardiovascular Lifetime Risk Pooling Project, which contains&amp;nbsp;data from 18 epidemiological studies including more than one-quarter of a million people whose risk factors-- blood pressure, cholesterol level, smoking status, and diabetes status--&amp;nbsp;were measured every decade between 45 and 75 years of age. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631117</comments>
            <pubDate>Wed, 25 Jan 2012 22:02:05 +0100</pubDate>
            <guid isPermaLink="false">5631117</guid>        </item>
        <item>
            <title>Embryonic stem cells: can we make the blind see?</title>
            <link>http://www.medworm.com/index.php?rid=5631118&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fstevensalzberg%2F2012%2F01%2F24%2Fembryonic-stem-cells-can-we-make-the-blind-see%2F</link>
            <description>In a new study, partial vision is restored to 2 patients with &quot;irreversible&quot; macular damage. Embryonic stem cells were used to repair the damage cells. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631118</comments>
            <pubDate>Wed, 25 Jan 2012 21:06:56 +0100</pubDate>
            <guid isPermaLink="false">5631118</guid>        </item>
        <item>
            <title>Health Insurance Premiums, the ACA, and a Third Way</title>
            <link>http://www.medworm.com/index.php?rid=5631119&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarolynmcclanahan%2F2012%2F01%2F25%2Fhealth-insurance-premiums-the-aca-and-a-third-way%2F</link>
            <description>Almost two years after the ACA was passed, it astounds me the number of people who still don't understand two important points regarding health insurance under the health care law: (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631119</comments>
            <pubDate>Wed, 25 Jan 2012 19:28:10 +0100</pubDate>
            <guid isPermaLink="false">5631119</guid>        </item>
        <item>
            <title>FDA Rejects Proposed Chronic Kidney Disease Indication for Vytorin</title>
            <link>http://www.medworm.com/index.php?rid=5631120&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F25%2Ffda-rejects-proposed-chronic-kidney-disease-indication-for-vytorin%2F</link>
            <description>The FDA rejected a new indication&amp;nbsp;for Merck's Vytorin and Zetia (ezetimibe plus simvastatin and ezetimibe alone) in chronic kidney disease patients. As a consolation prize, however, the agency approved a new label for Vytorin that will incorporate the results of SHARP (Study of Heart and Renal Protection), which found that Vytorin reduced the incidence of major vascular events in patients with chronic kidney disease. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631120</comments>
            <pubDate>Wed, 25 Jan 2012 18:02:57 +0100</pubDate>
            <guid isPermaLink="false">5631120</guid>        </item>
        <item>
            <title>Investors Expect Illumina To Fetch More Than Roche's Hostile Offer</title>
            <link>http://www.medworm.com/index.php?rid=5631121&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F25%2Finvestors-expect-illumina-to-fetch-more-than-roches-hostile-offer%2F</link>
            <description>Shares in Illumina, the leading maker of DNA sequencing equipment, jumped 45% in morning trading after the drug giant Roche made a $5.7 billion hostile offer for the company. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631121</comments>
            <pubDate>Wed, 25 Jan 2012 16:05:26 +0100</pubDate>
            <guid isPermaLink="false">5631121</guid>        </item>
        <item>
            <title>The Case For Investing in the IRS</title>
            <link>http://www.medworm.com/index.php?rid=5631122&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Finsider%2F2012%2F01%2F25%2Fthe-case-for-investing-in-the-irs%2F</link>
            <description>Most American taxpayers would not consider the IRS to be underfunded, let alone the IRS’s need for more resources to be the most serious problem they face. Given the growing “tax gap” (i.e., the amount of all unpaid tax liabilities), however, a persuasive case can be made that the government should invest more in the IRS’s budget. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631122</comments>
            <pubDate>Wed, 25 Jan 2012 15:16:10 +0100</pubDate>
            <guid isPermaLink="false">5631122</guid>        </item>
        <item>
            <title>State of the ... Health Care Reform</title>
            <link>http://www.medworm.com/index.php?rid=5631123&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F25%2Fstate-of-the-health-care-reform%2F</link>
            <description>President Obama's largest legislative accomplishment to date was the passage of the health care reform law, which has been going into effect in stages, with regulations currently being written for the most substantial changes due to take effect in 2014. So it is odd the President mentioned health care only briefly, and in passing, in his State of the Union address last night. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631123</comments>
            <pubDate>Wed, 25 Jan 2012 07:45:36 +0100</pubDate>
            <guid isPermaLink="false">5631123</guid>        </item>
        <item>
            <title>Roche's Hostile Bid For Illumina Ups Stakes In DNA Tech Race</title>
            <link>http://www.medworm.com/index.php?rid=5631124&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F24%2Froches-hostile-bid-ups-stakes-in-dna-tech-race%2F</link>
            <description>In an attempt to buy a leading position in the emerging field of DNA sequencing, Roche, a Basel, Switzerland-based drug giant, initiated a $5.7 billion tender offer to buy the outstanding shares of Illumina, the San Diego-based leader in genetic research equipment, despite rebuffs by Illumina's chief executive and board. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631124</comments>
            <pubDate>Wed, 25 Jan 2012 04:08:24 +0100</pubDate>
            <guid isPermaLink="false">5631124</guid>        </item>
        <item>
            <title>The &quot;Cadillac of Care&quot; For Dad</title>
            <link>http://www.medworm.com/index.php?rid=5631125&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarolynrosenblatt%2F2012%2F01%2F24%2Fthe-cadillac-of-care-for-dad%2F</link>
            <description>Financial success is no protection against dementia.&amp;nbsp; Neither is status in society. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631125</comments>
            <pubDate>Wed, 25 Jan 2012 01:31:04 +0100</pubDate>
            <guid isPermaLink="false">5631125</guid>        </item>
        <item>
            <title>NUVA Upgraded To BUY</title>
            <link>http://www.medworm.com/index.php?rid=5631126&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcanaccordgenuity%2F2012%2F01%2F24%2Fnuva-upgraded-to-buy%2F</link>
            <description>Calling the company a “Top Quality Asset At A Rock Bottom Price”, Canaccord Genuity life sciences analyst William Plovanic upgraded his NuVasive (NUVA) rating to BUY and reiterated his $19 price target on the company. Mr. Plovanic said: (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631126</comments>
            <pubDate>Tue, 24 Jan 2012 19:27:44 +0100</pubDate>
            <guid isPermaLink="false">5631126</guid>        </item>
        <item>
            <title>Sir Richard Branson Urges Experimentation in Drug Legislation</title>
            <link>http://www.medworm.com/index.php?rid=5631127&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdanielnyegriffiths%2F2012%2F01%2F24%2Fbranson-drugs-westminster%2F</link>
            <description>There was a moment during Sir Richard Branson's testimony to Britain's Home Office Select Committee, which took place on Tuesday morning, which illustrated the conceptual gulf between the worlds of politics and business. Branson was explaining that businesses in his Virgin group sought to offer employment to young people leaving prison. The stability, money and self-esteem conferred by regular employment helped young people to stay on the right side of the law in future. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631127</comments>
            <pubDate>Tue, 24 Jan 2012 19:22:47 +0100</pubDate>
            <guid isPermaLink="false">5631127</guid>        </item>
        <item>
            <title>No Mention of Health Care in White House's State of the Union Talking Points</title>
            <link>http://www.medworm.com/index.php?rid=5631128&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F24%2Fno-mention-of-health-care-in-white-houses-state-of-the-union-talking-points%2F</link>
            <description>This morning, the White House put out their talking points for President Obama’s State of the Union address, which is taking place tonight. According to the memo, the President will “lay out a blueprint for an economy built on American manufacturing, American energy, skills for American workers, and a renewal of American values.” Remarkably, the memo makes no mention of health care: neither the President’s signature legislative achievement, nor his thoughts on entitlement reform. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631128</comments>
            <pubDate>Tue, 24 Jan 2012 18:54:15 +0100</pubDate>
            <guid isPermaLink="false">5631128</guid>        </item>
        <item>
            <title>Whistleblower Lawsuit Filed Against 5 Cardiologists in Pennsylvania</title>
            <link>http://www.medworm.com/index.php?rid=5631129&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F24%2Fwhistleblower-lawsuit-filed-against-5-cardiologists-in-pennsylvania%2F</link>
            <description>The US government has joined a cardiologist in a whistleblower lawsuit against Hamot Medical Center &amp;nbsp;in western Pennsylvania &amp;nbsp;and a group of cardiologists with whom he once practiced, Ed Palattella&amp;nbsp;reports in the Erie Times-News. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631129</comments>
            <pubDate>Tue, 24 Jan 2012 16:43:02 +0100</pubDate>
            <guid isPermaLink="false">5631129</guid>        </item>
        <item>
            <title>Black Tea Found To Lower Blood Pressure</title>
            <link>http://www.medworm.com/index.php?rid=5631130&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F24%2Fblack-tea-found-to-lower-blood-pressure%2F</link>
            <description>A new study published in Archives of Internal Medicine provides the best evidence yet that drinking black tea can lower blood pressure.&amp;nbsp;Jonathan M. Hodgson and colleagues randomized 95 regular tea drinkers to either&amp;nbsp;3 cups per day of either black tea (containing 429 mg of polyphenols and 96 mg of caffeine) or placebo. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631130</comments>
            <pubDate>Tue, 24 Jan 2012 14:38:46 +0100</pubDate>
            <guid isPermaLink="false">5631130</guid>        </item>
        <item>
            <title>Physician Pay: A Big Driver of Health Care Costs?</title>
            <link>http://www.medworm.com/index.php?rid=5621667&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarolynmcclanahan%2F2012%2F01%2F19%2Fphysician-pay-a-big-driver-of-health-care-costs%2F</link>
            <description>It is a good time to address physician pay and how this affects health care costs. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621667</comments>
            <pubDate>Tue, 24 Jan 2012 02:35:10 +0100</pubDate>
            <guid isPermaLink="false">5621667</guid>        </item>
        <item>
            <title>The One Success Story Romney Can't Discuss</title>
            <link>http://www.medworm.com/index.php?rid=5621669&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fkenrapoza%2F2012%2F01%2F23%2Fthe-one-success-story-romney-cant-discuss%2F</link>
            <description>Politics is not without its bitter ironies, but none is greater in this presidential election campaign than the one plaguing Mitt Romney. Talk about a dilemma. The man's biggest success story in his political career is the one story his party's voters don't want to hear. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621669</comments>
            <pubDate>Tue, 24 Jan 2012 00:06:52 +0100</pubDate>
            <guid isPermaLink="false">5621669</guid>        </item>
        <item>
            <title>Drug Execs May Wish They'd Never Heard Of Paula Deen</title>
            <link>http://www.medworm.com/index.php?rid=5621668&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F17%2Fwhy-drug-execs-might-wish-theyd-never-heard-of-paula-deen%2F</link>
            <description>Paula Deen will be good for Novo Nordisk's sales -- but bad for the drug industry as a whole. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621668</comments>
            <pubDate>Mon, 23 Jan 2012 22:13:27 +0100</pubDate>
            <guid isPermaLink="false">5621668</guid>        </item>
        <item>
            <title>In South Carolina, Santorum Made the Case against Romneycare</title>
            <link>http://www.medworm.com/index.php?rid=5621670&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F23%2Fat-gop-debate-santorum-makes-the-case-against-romneycare%2F</link>
            <description>Well, we’re finally getting somewhere in the Republican Presidential race. The field has been winnowed. Though I would have preferred a different final four, the smaller group allows for more detailed exploration of the issues, something that’s particularly important with health care. And the January 19 debate in Charleston, South Carolina provided the best discussion yet of the candidates’ views on health policy. Many opportunities were seized, but a few big ones were missed. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621670</comments>
            <pubDate>Mon, 23 Jan 2012 22:07:28 +0100</pubDate>
            <guid isPermaLink="false">5621670</guid>        </item>
        <item>
            <title>St Jude Medical Statement on the Riata ICD Lead Summit</title>
            <link>http://www.medworm.com/index.php?rid=5621671&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F23%2Fst-jude-medical-statement-on-the-riata-icd-lead-summit%2F</link>
            <description>In response to the guest post summarizing the Riata ICD Lead Summit, St. Jude Medical sent the following statement to CardioBrief:
We recognize that the phenomenon of externalized conductors presents a complex patient management scenario for physicians who may be able to visualize an anomaly, but it is important to remember that most leads with externalized conductors continue to function properly. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621671</comments>
            <pubDate>Mon, 23 Jan 2012 19:04:17 +0100</pubDate>
            <guid isPermaLink="false">5621671</guid>        </item>
        <item>
            <title>Rita Redberg and Roger Blumenthal Clash Over Statins for Primary Prevention in the Wall Street Journal</title>
            <link>http://www.medworm.com/index.php?rid=5621672&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F23%2Frita-redberg-and-roger-blumenthal-clash-over-statins-for-primary-prevention-in-the-wall-street-journal%2F</link>
            <description>The debate over whether statins should be used for primary prevention moved to the Wall Street Journal with opposing perspectives from cardiologists Roger Blumenthal and Rita Redberg. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621672</comments>
            <pubDate>Mon, 23 Jan 2012 18:08:43 +0100</pubDate>
            <guid isPermaLink="false">5621672</guid>        </item>
        <item>
            <title>10 Products That Will Make Your Life Easier- Part II</title>
            <link>http://www.medworm.com/index.php?rid=5621673&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fannakupka%2F2012%2F01%2F23%2F10-products-that-will-make-your-life-easier-part-ii%2F</link>
            <description>One product that I don’t have but that many of my friends rave about – and it seems that you cannot find a single household in Munich without it anymore is the all-in-one kitchen machine “Thermomix” by German company Vorwerk. The machine is not cheap but apparently it can do (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621673</comments>
            <pubDate>Mon, 23 Jan 2012 16:33:49 +0100</pubDate>
            <guid isPermaLink="false">5621673</guid>        </item>
        <item>
            <title>12 Teens Who Suddenly Developed Involuntary Tics Get Diagnosis: Conversion Disorder</title>
            <link>http://www.medworm.com/index.php?rid=5621674&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Falicegwalton%2F2012%2F01%2F23%2F12-teens-who-suddenly-developed-involuntary-tics-get-diagnosis-conversion-disorder%2F</link>
            <description>Several months ago and virtually over night, 12 teenage girls at LeRoy High School in upstate New York developed Tourette’s-like symptoms, including neurological tics and verbal outbursts. The school has been tested for all kinds of environmental toxins, but none was discovered. Now, one of the doctors treating the girls has revealed the diagnosis: Conversion disorder. Once upon a time, this would have been called “mass hysteria,” but nowadays, conversion disorder is a recognized affliction with very real symptoms. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621674</comments>
            <pubDate>Mon, 23 Jan 2012 15:59:26 +0100</pubDate>
            <guid isPermaLink="false">5621674</guid>        </item>
        <item>
            <title>Is This The End Of The Half Million-Dollar DNA Sequencer?</title>
            <link>http://www.medworm.com/index.php?rid=5621675&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F23%2Fis-this-the-end-of-the-half-million-dollar-dna-sequencer%2F</link>
            <description>On January 10, Life Technologies and Illumina both announced plans for faster, same-day DNA sequencers. One difference: Life's machine, the Ion Proton, is considerably cheaper.&amp;nbsp;In a note to his clients this morning, Macquarie Capital analyst Jon Groberg opines:
The one thing we feel we can say with certainty following these announcements is that we expect a radical resetting of price expectations going forward in the sequencing market. At US$149K (US$244K if you assume a server and Onetouchdevice with each Proton), the Proton sells for 20% (or 33%) of the US$740K HiSeq 2500. We believe this announcement marks the beginning of the end of US$500K+ instruments, which we see as a more significant headwind for ILMN.
Another interesting note: at the AGBT meeting in Florida (also known as ...</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621675</comments>
            <pubDate>Mon, 23 Jan 2012 14:53:19 +0100</pubDate>
            <guid isPermaLink="false">5621675</guid>        </item>
        <item>
            <title>Why are Kids Choking Themselves in Texas?</title>
            <link>http://www.medworm.com/index.php?rid=5621676&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdaviddisalvo%2F2012%2F01%2F22%2Fwhy-are-kids-choking-themselves-in-texas%2F</link>
            <description>A study of Texas college students finds that one out of seven has participated in the &quot;Choking Game,&quot; a behavior that&amp;nbsp;deliberately&amp;nbsp;cuts off blood flow to the brain to receive a high. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621676</comments>
            <pubDate>Mon, 23 Jan 2012 01:52:22 +0100</pubDate>
            <guid isPermaLink="false">5621676</guid>        </item>
        <item>
            <title>Stossel Is Right For Demonizing The Demonization Of Physician-Industry Relationships</title>
            <link>http://www.medworm.com/index.php?rid=5621677&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidshaywitz%2F2012%2F01%2F22%2Fstossel-is-right-for-demonizing-the-demonization-of-physician-industry-relationships%2F</link>
            <description>Monday’s WSJ (online now) features an exceptionally important and courageous op-ed by Harvard professor (and frequent co-author of mine, although not in this case) Tom Stossel, discussing a rule within recently enacted healthcare legislation with the Orwellian title, “The Physician Payment Sunshine Act,” focused on physician/industry relationships. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621677</comments>
            <pubDate>Mon, 23 Jan 2012 01:15:47 +0100</pubDate>
            <guid isPermaLink="false">5621677</guid>        </item>
        <item>
            <title>Guest Post: Report from the Riata ICD Lead Summit</title>
            <link>http://www.medworm.com/index.php?rid=5621678&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F21%2Fguest-post-report-from-the-riata-icd-lead-summit%2F</link>
            <description>Update:&amp;nbsp;Click here to read a statement from St Jude Medical in response to this post. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621678</comments>
            <pubDate>Sat, 21 Jan 2012 15:57:54 +0100</pubDate>
            <guid isPermaLink="false">5621678</guid>        </item>
        <item>
            <title>Millennials Divorce Marriage (Part 2)</title>
            <link>http://www.medworm.com/index.php?rid=5621679&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fprospernow%2F2012%2F01%2F21%2Fmillennials-divorce-marriage-part-2%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621679</comments>
            <pubDate>Sat, 21 Jan 2012 14:44:05 +0100</pubDate>
            <guid isPermaLink="false">5621679</guid>        </item>
        <item>
            <title>Keen to drive science into medicine? Four lessons from an innovation conference.</title>
            <link>http://www.medworm.com/index.php?rid=5621680&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidshaywitz%2F2012%2F01%2F21%2Fkeen-to-drive-science-into-medicine-four-lessons-from-an-innovation-conference%2F</link>
            <description>I’ve just returned from participating in an engaging and highly interactive translational research innovation symposium at Duke University this past Thursday put together by Dr. David Epstein at the Duke Eye Center and Chancellor Victor Dzau, and featuring both University faculty and invited external speakers.&amp;nbsp; Four key themes emerged: (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621680</comments>
            <pubDate>Sat, 21 Jan 2012 07:46:57 +0100</pubDate>
            <guid isPermaLink="false">5621680</guid>        </item>
        <item>
            <title>A Quant's View on the Resignations of TIAA-CREF's President, and the Co-Founder of Vanda Pharmaceuticals</title>
            <link>http://www.medworm.com/index.php?rid=5621681&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fkaipetainen%2F2012%2F01%2F21%2Fa-quants-view-on-the-resignations-of-tiaa-crefs-president-and-the-co-founder-of-vanda-pharmaceuticals%2F</link>
            <description>Last week I wrote about Vanda Pharmaceuticals (NASDAQ:VNDA) and TIAA-CREF.&amp;nbsp; I wrote about how TIAA-CREF had a large position in Vanda Pharmaceuticals and how TIAA-CREF had placed a micro-cap stock into a large-cap portfolio.&amp;nbsp; Normally I would not write about micro-cap stocks, but as it was&amp;nbsp;being held in a large-cap fund at a huge firm, I felt that it was fair game to talk about VNDA.&amp;nbsp; I was puzzled as to why TIAA-CREF would place a micro-cap stock into a large-cap portfolio, as the stock seemed to be of an inappropriate market-cap for the fund.&amp;nbsp; As a comparison, Fidelity, TIAA-CREF’s competitor, had not placed VNDA into their large-cap portfolios.&amp;nbsp; I wanted to ask TIAA-CREF, why do you have VNDA? (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5621681</comments>
            <pubDate>Sat, 21 Jan 2012 06:51:07 +0100</pubDate>
            <guid isPermaLink="false">5621681</guid>        </item>
        <item>
            <title>Scientists Developing Deadly Bird Flu Mutations Agree to Pause Research</title>
            <link>http://www.medworm.com/index.php?rid=5612159&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdaviddisalvo%2F2012%2F01%2F21%2Fscientists-developing-deadly-bird-flu-mutations-agree-to-pause-research%2F</link>
            <description>Amid growing controversy, scientists in two laboratories have agreed to temporarily suspend their work on mutations of the&amp;nbsp;H5N1 influenza virus, or bird flu,&amp;nbsp;according to&amp;nbsp;a letter published in the journals Nature and Science. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612159</comments>
            <pubDate>Sat, 21 Jan 2012 05:36:02 +0100</pubDate>
            <guid isPermaLink="false">5612159</guid>        </item>
        <item>
            <title>Tysabri: The Model For Facing A Drug Safety Crisis</title>
            <link>http://www.medworm.com/index.php?rid=5612160&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F20%2Ftysabri-the-model-for-facing-a-drug-safety-crisis%2F</link>
            <description>After a decade of drug safety crises where medicines have mostly either wound up yanked (Vioxx, Zelnorm) or close to it (Avandia), today's news about the multiple sclerosis drug Tysabri is positively amazing. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612160</comments>
            <pubDate>Fri, 20 Jan 2012 22:31:38 +0100</pubDate>
            <guid isPermaLink="false">5612160</guid>        </item>
        <item>
            <title>After The Risperdal Trial, J&amp;J Looks More Like Humpty-Dumpty</title>
            <link>http://www.medworm.com/index.php?rid=5612161&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fedsilverman%2F2012%2F01%2F20%2Fafter-the-risperdal-trial-jj-looks-more-like-humpty-dumpty%2F</link>
            <description>Now&amp;nbsp;that Johnson &amp; Johnson has agreed to pay $158 million to settle a lawsuit in which the Texas Attorney General charged the drugmaker with a whopper of a scheme to illegally promote its Risperdal antipsychotic, a couple of questions must be asked: why was a deal not made&amp;nbsp;sooner? Moreover,&amp;nbsp;why did Johnson &amp; Johnson risk further damaging its tattered reputation by going to court to fight a lawsuit that media reports indicated months earlier would easily cast the drugmaker in a terrible light? (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612161</comments>
            <pubDate>Fri, 20 Jan 2012 19:58:13 +0100</pubDate>
            <guid isPermaLink="false">5612161</guid>        </item>
        <item>
            <title>Bears Bet Medivation Loses Levitation, Bulls Find Fertile Upside In Mosaic</title>
            <link>http://www.medworm.com/index.php?rid=5612162&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fgreatspeculations%2F2012%2F01%2F20%2Fbears-bet-medivation-loses-levitation-bulls-find-fertile-upside-in-mosaic%2F</link>
            <description>Today’s tickers: MFC, MDVN &amp; MOS (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612162</comments>
            <pubDate>Fri, 20 Jan 2012 19:57:26 +0100</pubDate>
            <guid isPermaLink="false">5612162</guid>        </item>
        <item>
            <title>Why Walgreens' Gamble on Glamming Up Drugstores Is a Winner</title>
            <link>http://www.medworm.com/index.php?rid=5612163&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flydiadishman%2F2012%2F01%2F20%2Fwhy-walgreens-gamble-on-glamming-up-drugstores-is-a-winner%2F</link>
            <description>Walgreens’ stealth mission to elevate the lowly drugstore from functional pharmacy to fab neighborhood lifestyle shop is in full swing. Starting with its winning bid for the&amp;nbsp;Duane Reade&amp;nbsp;drugstore chain in 2010,&amp;nbsp;Walgreens&amp;nbsp;acquired Drugstore.com&amp;nbsp;in a&amp;nbsp;$429 million deal last March and is now unveiling its luxe concept with a new two-story flagship location on Chicago’s historic State Street.&amp;nbsp;Will customers be willing to get a manicure and a bottle of Merlot while they’re trawling for Motrin and Maalox? (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612163</comments>
            <pubDate>Fri, 20 Jan 2012 19:17:20 +0100</pubDate>
            <guid isPermaLink="false">5612163</guid>        </item>
        <item>
            <title>A SCOTUS Ordered End To Health Insurance Mandates Means Big Trouble For GOP Presidential Candidate</title>
            <link>http://www.medworm.com/index.php?rid=5612158&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Frickungar%2F2012%2F01%2F16%2Fa-scotus-ordered-end-to-health-insurance-mandates-means-big-trouble-for-gop-presidential-candidate%2F</link>
            <description>Image via Wikipedia Despite the bravado exhibited by the GOP presidential candidates—each angling to outdo the other when promising to enter the White House with guns ablazin’ for the Affordable Care Act—their rhetoric is fraught with some very real dangers to their party—not to mention the nation—when it comes to actually (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612158</comments>
            <pubDate>Fri, 20 Jan 2012 16:19:00 +0100</pubDate>
            <guid isPermaLink="false">5612158</guid>        </item>
        <item>
            <title>Friday Reads: Paula Deen &amp; Company</title>
            <link>http://www.medworm.com/index.php?rid=5612164&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmickeymeece%2F2012%2F01%2F20%2Ffriday-reads-paula-deen-company%2F</link>
            <description>The Food Network personality Paula Deen acknowledged this week that she was diagnosed with Type II diabetes, according to         The Consumerist, and that she was a paid spokeswoman for Novo Nordisk’s awareness effort, www.diabetesinanewlight.com. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612164</comments>
            <pubDate>Fri, 20 Jan 2012 15:09:21 +0100</pubDate>
            <guid isPermaLink="false">5612164</guid>        </item>
        <item>
            <title>Big Data Delivers Deep Views Of Patients For Better Care</title>
            <link>http://www.medworm.com/index.php?rid=5612165&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ftomgroenfeldt%2F2012%2F01%2F20%2Fbig-data-delivers-deep-views-of-patients-for-better-care%2F</link>
            <description>Big Data has arrived st Seton Health Care Family, fortunately accompanied by an analytics tool that will help deal with the complexity of more than two million patient contacts a year, usually attended by dozens of existing patient record pages and generating more with each visit -- some electronic, many notes in phyiscian’s infamous handwriting, some transcribed from dictation and others jotted down on X-rays. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612165</comments>
            <pubDate>Fri, 20 Jan 2012 14:45:02 +0100</pubDate>
            <guid isPermaLink="false">5612165</guid>        </item>
        <item>
            <title>7 &quot;Healthy&quot; Foods That Pack A Hefty Fat Punch</title>
            <link>http://www.medworm.com/index.php?rid=5612166&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmelaniehaiken%2F2012%2F01%2F20%2F7-healthy-foods-that-pack-a-fat-punch%2F</link>
            <description>It's mid-January, and you're still on track to fulfill your New Year's resolution to eat healthier and lose weight. You finally broke your soda habit, you avert your eyes in the cookie aisle, and you make yourself eat popcorn instead of chips whenever possible. But you might be shocked -- and not a little upset -- to find out that some of the &quot;healthy&quot; snacks that now fill your cupboards are packed with hidden fat, sugar, and calories. (But guess what? some foods actually burn fat. Those are the ones you want to eat more of.) Here are just a few of the worst culprits lurking on health food store shelves. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612166</comments>
            <pubDate>Fri, 20 Jan 2012 10:19:46 +0100</pubDate>
            <guid isPermaLink="false">5612166</guid>        </item>
        <item>
            <title>U.S. Healthcare Hits $3 Trillion</title>
            <link>http://www.medworm.com/index.php?rid=5612167&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdanmunro%2F2012%2F01%2F19%2Fu-s-healthcare-hits-3-trillion%2F</link>
            <description>Great post by Rick Ungar over on The Policy Page. &amp;nbsp;Still, I’m left wondering.&amp;nbsp; It’s an election year and given the stakes, I think we’ll look back on 2012 as the year of the great Healthcare Reform debate – Part 2.&amp;nbsp; What we have today is really just the beginning of a long and winding investment in Healthcare Reform - Part 1. &amp;nbsp;I think the question remains &amp;nbsp;- have we tamed the cost beast with real legislation – or is it just legislation around the edges? &amp;nbsp;Here’s why I'm wondering. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612167</comments>
            <pubDate>Fri, 20 Jan 2012 04:52:13 +0100</pubDate>
            <guid isPermaLink="false">5612167</guid>        </item>
        <item>
            <title>CT Angiography Found Less Helpful in Patients With High Calcium Scores</title>
            <link>http://www.medworm.com/index.php?rid=5612168&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F19%2Fct-angiography-found-less-helpful-in-patients-with-high-calcium-scores%2F</link>
            <description>Computed tomography angiography (CTA) has been proposed as a less invasive method to exclude obstructive coronary artery disease (CAD), but no consensus has been achieved about its clinical role in different patient subsets. Now a new report published in JACC from&amp;nbsp;the CORE-64&amp;nbsp;(Coronary Artery Evaluation Using 64-Row Multidetector Computed Tomography Angiography) study shows that CTA may not be worthwhile in people with a calcium score of 600 or above or who already have a high pre-test probability of having CAD. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612168</comments>
            <pubDate>Thu, 19 Jan 2012 19:02:41 +0100</pubDate>
            <guid isPermaLink="false">5612168</guid>        </item>
        <item>
            <title>Should You Buy Long-Term Care Insurance? Maybe Not</title>
            <link>http://www.medworm.com/index.php?rid=5612157&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fhowardgleckman%2F2012%2F01%2F18%2Fshould-you-buy-long-term-care-insurance-maybe-not%2F</link>
            <description>Private long-term care insurance can be an important tool to protect against the risk of needing costly personal assistance in old age. But two respected financial economists conclude it is very expensive relative to the benefits it provides and may not be appropriate for many buyers. At the same time, (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612157</comments>
            <pubDate>Thu, 19 Jan 2012 18:13:50 +0100</pubDate>
            <guid isPermaLink="false">5612157</guid>        </item>
        <item>
            <title>US Incomes Are Rising But It's All Going on Health Care</title>
            <link>http://www.medworm.com/index.php?rid=5612169&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ftimworstall%2F2012%2F01%2F19%2Fus-incomes-are-rising-but-its-all-going-on-health-care%2F</link>
            <description>A very nice observation here from Tim Taylor. We're all aware of the figures that show that US incomes aren't rising, that median income has been static and so on. However, this isn't quite the right way to measure it, just wage income. We really ought to use labour compensation and that has been rising. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612169</comments>
            <pubDate>Thu, 19 Jan 2012 18:01:20 +0100</pubDate>
            <guid isPermaLink="false">5612169</guid>        </item>
        <item>
            <title>What Online Tools Do Neuroscientists Wish Existed to Facilitate Their Work?</title>
            <link>http://www.medworm.com/index.php?rid=5612170&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fquora%2F2012%2F01%2F19%2Fwhat-online-tools-do-neuroscientists-wish-existed-to-facilitate-their-work%2F</link>
            <description>Josh Siegle, PhD student at MIT (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612170</comments>
            <pubDate>Thu, 19 Jan 2012 15:44:44 +0100</pubDate>
            <guid isPermaLink="false">5612170</guid>        </item>
        <item>
            <title>Billion Dollar Quarterly Research &amp; Development Club: Who Turns R&amp;D Into Stockholder Gains?</title>
            <link>http://www.medworm.com/index.php?rid=5612171&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fycharts%2F2012%2F01%2F19%2Fbillion-dollar-quarterly-research-development-club-who-turns-rd-into-stockholder-gains%2F</link>
            <description>Looking for stocks with long-term growth potential? Theoretically, at least, companies pouring money into researching new products should offer great shareholder returns, as laboratories churn out patentable and marketable inventions. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612171</comments>
            <pubDate>Thu, 19 Jan 2012 15:39:00 +0100</pubDate>
            <guid isPermaLink="false">5612171</guid>        </item>
        <item>
            <title>With A $3 Egg Timer You Can Change The World</title>
            <link>http://www.medworm.com/index.php?rid=5612172&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdavidwhelan%2F2012%2F01%2F18%2Fwith-a-3-egg-timer-you-can-change-the-world%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612172</comments>
            <pubDate>Thu, 19 Jan 2012 03:57:55 +0100</pubDate>
            <guid isPermaLink="false">5612172</guid>        </item>
        <item>
            <title>Guest Post: A Critical Analysis of ABC &amp; Bill Weir's &quot;Lifesaving Test&quot; Story</title>
            <link>http://www.medworm.com/index.php?rid=5612173&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F18%2Fguest-post-a-critical-analysis-of-abc-bill-weirs-lifesaving-test-story%2F</link>
            <description>Editor’s Note: The following guest post by Gary Schwitzer is reprinted with permission from his HealthNewsReview blog, an indispensable resource for tracking the best and worst of healthcare journalism.
A critical analysis of ABC &amp; Bill Weir’s “lifesaving test” story
by Gary Schwitzer (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612173</comments>
            <pubDate>Wed, 18 Jan 2012 20:21:10 +0100</pubDate>
            <guid isPermaLink="false">5612173</guid>        </item>
        <item>
            <title>FAME II: Additional Thoughts About FFR in the Real World</title>
            <link>http://www.medworm.com/index.php?rid=5612174&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F18%2Ffame-ii-additional-thoughts-about-ffr-in-the-real-world%2F</link>
            <description>Earlier today&amp;nbsp;I reported the news that enrollment in the FAME II study had been stopped early by the DSMB. From the initial presentation of the first FAME trial several years ago, I've been fascinated by the potential of this technology, since it offers the tantalizing prospect of helping identify atherosclerotic lesions that actually will benefit from an intervention.&amp;nbsp;But FFR is not a free ride. The downside is that you have to perform a lesser intervention (angiography) in order to determine the validity of the greater intervention (PCI). (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612174</comments>
            <pubDate>Wed, 18 Jan 2012 19:31:40 +0100</pubDate>
            <guid isPermaLink="false">5612174</guid>        </item>
        <item>
            <title>Is the Conservative Establishment Against Entitlement Reform?</title>
            <link>http://www.medworm.com/index.php?rid=5612175&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F18%2Fis-the-conservative-establishment-against-entitlement-reform%2F</link>
            <description>One of the oddest aspects of the last six months has been the degree to which the Republican base has embraced symbolic (9-9-9) over substantive (Paul Ryan) positions on entitlement reform from the GOP Presidential field. Why is this happening? Over at Redstate.com, bastion of populist conservatism, Dan McLaughlin thinks he has the answer. But in fact, his essay answers a different question: why it is that conservative voters remain woefully unprepared to tackle the fiscal challenges ahead. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612175</comments>
            <pubDate>Wed, 18 Jan 2012 18:35:49 +0100</pubDate>
            <guid isPermaLink="false">5612175</guid>        </item>
        <item>
            <title>New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR</title>
            <link>http://www.medworm.com/index.php?rid=5612176&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F18%2Fnew-enrollment-in-fame-ii-halted-after-interim-analysis-shows-benefits-of-ffr%2F</link>
            <description>Following a positive interim analysis showing that fractional flow-reserve-guided PCI was superior to optimal medical treatment, an independent Data and Safety Monitoring Board (DSMB) has recommended that patient enrollment in&amp;nbsp;the ongoing&amp;nbsp;FAME II trial be stopped. The news was announced by the trial sponsor, St. Jude Medical. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612176</comments>
            <pubDate>Wed, 18 Jan 2012 15:33:47 +0100</pubDate>
            <guid isPermaLink="false">5612176</guid>        </item>
        <item>
            <title>The Drug Hunters Of 2037</title>
            <link>http://www.medworm.com/index.php?rid=5612177&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F18%2Fthe-drug-hunters-of-2037%2F</link>
            <description>What will the drug business look like in 25 years? Sure it's a bit of a parlor game, but also a way of getting one's bearings in a fast-moving field. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612177</comments>
            <pubDate>Wed, 18 Jan 2012 15:30:09 +0100</pubDate>
            <guid isPermaLink="false">5612177</guid>        </item>
        <item>
            <title>Hospital Director Sentenced to 3 Years in Federal Prison in Construction Kickback Scheme</title>
            <link>http://www.medworm.com/index.php?rid=5612178&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fbillsinger%2F2012%2F01%2F18%2Fhospital-director-sentenced-to-3-years-in-federal-prison-in-construction-kickback-scheme%2F</link>
            <description>Sometimes you just have to wonder if there aren't some depths to which human beings won't sink. &amp;nbsp;Frankly, the more you follow the news, the more likely it is that you become cynical and accept the fact that there's virtually no limit to what some lowlifes will do to make a buck, a dishonest one at that. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5612178</comments>
            <pubDate>Wed, 18 Jan 2012 14:01:46 +0100</pubDate>
            <guid isPermaLink="false">5612178</guid>        </item>
        <item>
            <title>10 States Where Employees Are More Likely to Embezzle And Who They Are</title>
            <link>http://www.medworm.com/index.php?rid=5600073&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ferikamorphy%2F2012%2F01%2F17%2F10-states-where-employees-are-more-likely-to-embezzle-and-who-they-are%2F</link>
            <description>This week a former Hardwick Electric Department office manager was sentenced to 3.5 years for embezzlement after pleading guilty last year. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600073</comments>
            <pubDate>Wed, 18 Jan 2012 01:09:50 +0100</pubDate>
            <guid isPermaLink="false">5600073</guid>        </item>
        <item>
            <title>Drug Found To Help Lower Clotting Risk Prior To Cardiac Surgery</title>
            <link>http://www.medworm.com/index.php?rid=5600074&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F17%2F1574%2F</link>
            <description>As a potent and reversible platelet inhibitor, cangrelor has been proposed for use in a bridging strategy for patients scheduled for surgery who are currently taking clopidogrel or another thienopyridine. To test this strategy, the BRIDGE investigators randomized 210 ACS or stent patients awaiting CABG and taking a thienopyridine to receive either cangrelor or placebo for at least 48 hours prior to surgery.&amp;nbsp;The results have now been published in&amp;nbsp;JAMA. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600074</comments>
            <pubDate>Tue, 17 Jan 2012 21:00:52 +0100</pubDate>
            <guid isPermaLink="false">5600074</guid>        </item>
        <item>
            <title>How Could Twitter Influence Science (And Why Scientists Are on Board)</title>
            <link>http://www.medworm.com/index.php?rid=5600072&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fhaydnshaughnessy%2F2012%2F01%2F15%2Fhow-could-twitter-influence-science-and-why-scientists-are-on-board%2F</link>
            <description>The recent revelation that Twitter and social media can influence science is good news for people who want to understand the broader impacts of a more social world. But does the evidence stack up? (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600072</comments>
            <pubDate>Tue, 17 Jan 2012 20:24:50 +0100</pubDate>
            <guid isPermaLink="false">5600072</guid>        </item>
        <item>
            <title>Specialty Pharma: 5 Themes for 2012; 4 Best Stock Ideas</title>
            <link>http://www.medworm.com/index.php?rid=5600075&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcanaccordgenuity%2F2012%2F01%2F17%2Fspecialty-pharma-5-themes-for-2012-4-best-stock-ideas%2F</link>
            <description>Canaccord Genuity&amp;nbsp;life sciences analyst Randall Stanicky called out five themes that will impact the specialty pharmaceutical sector along with his top picks for 2012.&amp;nbsp; The themes are (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600075</comments>
            <pubDate>Tue, 17 Jan 2012 19:50:09 +0100</pubDate>
            <guid isPermaLink="false">5600075</guid>        </item>
        <item>
            <title>The iPad 3: A Shiny New Object for Hackers?</title>
            <link>http://www.medworm.com/index.php?rid=5600076&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ferikamorphy%2F2012%2F01%2F17%2Fthe-ipad3-a-shiny-new-object-for-hackers%2F</link>
            <description>IDC has released statistics that are both sobering for computer security execs and downright eye-candy for hackers:&amp;nbsp; 91 percent of people globally who own an iPad use it for work. In fact, it appears as though iPads are becoming de facto work devices, with only some use devoted to personal surfing, content viewing etc. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600076</comments>
            <pubDate>Tue, 17 Jan 2012 15:26:40 +0100</pubDate>
            <guid isPermaLink="false">5600076</guid>        </item>
        <item>
            <title>Deadly Dangers from Drugstore Pain Meds a Painful Surprise</title>
            <link>http://www.medworm.com/index.php?rid=5600077&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmelaniehaiken%2F2012%2F01%2F17%2Fdeadly-dangers-from-drugstore-pain-meds-a-painful-surprise%2F</link>
            <description>Could your attempts to cope with common headaches, sore knees or backache be putting you at risk for heart attack, stroke and liver disease? Recent research suggests that both ibuprofen and acetominophen -- the two most popular over-the-counter painkillers -- carry some potentially and even deadly risks. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600077</comments>
            <pubDate>Tue, 17 Jan 2012 10:54:27 +0100</pubDate>
            <guid isPermaLink="false">5600077</guid>        </item>
        <item>
            <title>Resveratrol and Fraud</title>
            <link>http://www.medworm.com/index.php?rid=5600078&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F16%2Fresveratrol-and-fraud%2F</link>
            <description>Last week a new case of scientific misconduct came to light. University of Connecticut resveratrol researcher Dipak Das was accused of serious scientific misconduct. (You can read my brief post about the case or, for all the gory details, you can follow&amp;nbsp;the story on Retraction Watch.) (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600078</comments>
            <pubDate>Mon, 16 Jan 2012 20:52:52 +0100</pubDate>
            <guid isPermaLink="false">5600078</guid>        </item>
        <item>
            <title>Why Medical Treatment is Going to Get Much Cheaper</title>
            <link>http://www.medworm.com/index.php?rid=5600079&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ftimworstall%2F2012%2F01%2F16%2Fwhy-medical-treatment-is-going-to-get-much-cheaper%2F</link>
            <description>We're normally told that the costs of medical treatment are going to get ever higher ever off into the future. I am deeply unconvinced that this is true myself for one simple reason. The onward march of medical technology. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600079</comments>
            <pubDate>Mon, 16 Jan 2012 17:52:11 +0100</pubDate>
            <guid isPermaLink="false">5600079</guid>        </item>
        <item>
            <title>UPDATE: Industrial Espionage at Dow Chemical</title>
            <link>http://www.medworm.com/index.php?rid=5600080&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fbillsinger%2F2012%2F01%2F16%2Fupdate-industrial-espionage-at-dow-chemical%2F</link>
            <description>This is an UPDATE of a Street Sweeper article originally published on February 8, 2011. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600080</comments>
            <pubDate>Mon, 16 Jan 2012 14:59:03 +0100</pubDate>
            <guid isPermaLink="false">5600080</guid>        </item>
        <item>
            <title>Healthcare Delivers Technical Knockout at CES</title>
            <link>http://www.medworm.com/index.php?rid=5600081&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fdanmunro%2F2012%2F01%2F16%2Fhealthcare-delivers-technical-knockout-at-ces%2F</link>
            <description>For those who don’t know boxing, there are three ways a fight ends.&amp;nbsp; The first is a clear knockout, the second is by vote of ringside judges and the third is when the referee in the ring ends the fight.&amp;nbsp; This last one is known as a technical knockout – or TKO for short.&amp;nbsp; I’m no boxing expert, but the boxing analogy is especially apt for this year’s Consumer Electronics Show (CES) in Las Vegas because there was a live boxing match inside one of the exhibit halls complete with a full size ring, stadium seating and real fighters.&amp;nbsp; I didn’t attend the match, but what I saw at CES was in many ways the equivalent of a TKO by an electronic device specifically for healthcare.&amp;nbsp; Hardened CES vets like Dan Costa (Executive Editor of PC-Mag.com) said it was &quot;the “c...</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600081</comments>
            <pubDate>Mon, 16 Jan 2012 06:31:51 +0100</pubDate>
            <guid isPermaLink="false">5600081</guid>        </item>
        <item>
            <title>Fitbit Aria Wi-Fi Scale Tracks Your Weight In The Cloud: CES</title>
            <link>http://www.medworm.com/index.php?rid=5600082&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ftomiogeron%2F2012%2F01%2F15%2Ffitbit-aria-wi-fi-scale-tracks-your-weight-in-the-cloud-ces%2F</link>
            <description>Startup Fitbit originally started out making a small device called the FitBit Ultra that tracks your steps and miles walked each day. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600082</comments>
            <pubDate>Mon, 16 Jan 2012 02:35:54 +0100</pubDate>
            <guid isPermaLink="false">5600082</guid>        </item>
        <item>
            <title>The Fate of Health Care Reform  --  What to Expect in 2012  --  NEJM</title>
            <link>http://www.medworm.com/index.php?rid=5586021&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarolynmcclanahan%2F2012%2F01%2F13%2Fthe-fate-of-health-care-reform-what-to-expect-in-2012-nejm%2F</link>
            <description>The Fate of Health Care Reform — What to Expect in 2012 — NEJM. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586021</comments>
            <pubDate>Sat, 14 Jan 2012 02:27:21 +0100</pubDate>
            <guid isPermaLink="false">5586021</guid>        </item>
        <item>
            <title>Will Obamacare Really Prohibit Active Medical Intervention At Age 70?</title>
            <link>http://www.medworm.com/index.php?rid=5586022&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Frickungar%2F2012%2F01%2F13%2Fwill-obamacare-end-active-medical-intervention-at-age-70%2F</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586022</comments>
            <pubDate>Fri, 13 Jan 2012 20:43:21 +0100</pubDate>
            <guid isPermaLink="false">5586022</guid>        </item>
        <item>
            <title>Secrets of the ACA: Are We Ready For Mass Casualties?</title>
            <link>http://www.medworm.com/index.php?rid=5586023&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarolynmcclanahan%2F2012%2F01%2F13%2Fsecrets-of-the-aca-are-we-ready-for-mass-casualties%2F</link>
            <description>For someone who desires to make things as simple as possible, it is ironic that my favorite reading is in the field of complexity science.&amp;nbsp; People historically have tried to understand the world as a series of machines.&amp;nbsp; The idea is if we break the machines down into smaller parts, not only can we understand it, we can manipulate it.&amp;nbsp; We all know intuitively the world isn’t that simple, and complexity science evolved as a way to accept that some events can’t be specifically prepared for, readily manipulated, or easily explained. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586023</comments>
            <pubDate>Fri, 13 Jan 2012 13:45:55 +0100</pubDate>
            <guid isPermaLink="false">5586023</guid>        </item>
        <item>
            <title>A Victory, Not A Conspiracy: Bill Gates And Ending Polio</title>
            <link>http://www.medworm.com/index.php?rid=5600083&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F12%2Fbill-gates-and-polio-victory-not-conspiracy%2F</link>
            <description>This morning brought a victory in humanity's battle against the germs that surround us, infect us, and define our history: polio virus appears to have been eliminated from India, one of only four nations in which the disease that paralyzed Franklin Delano Roosevelt is still endemic. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600083</comments>
            <pubDate>Thu, 12 Jan 2012 19:07:57 +0100</pubDate>
            <guid isPermaLink="false">5600083</guid>        </item>
        <item>
            <title>The Safety of the Long Distance Runner</title>
            <link>http://www.medworm.com/index.php?rid=5600084&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F12%2Fthe-safety-of-the-long-distance-runner%2F</link>
            <description>Long distance runners may be lonely but they are not at high risk for sudden cardiac arrest,&amp;nbsp;according to a study published in the New England Journal of Medicine. The RACER (Race Associated Cardiac Arrest Event Registry) investigators analyzed data from 10.9 million registered participants in marathons and half-marathons that took place in the US during the first decade of this century. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600084</comments>
            <pubDate>Thu, 12 Jan 2012 18:23:15 +0100</pubDate>
            <guid isPermaLink="false">5600084</guid>        </item>
        <item>
            <title>DNA Sequencing Is Now Improving Faster Than Moore's Law!</title>
            <link>http://www.medworm.com/index.php?rid=5586024&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Ftechonomy%2F2012%2F01%2F12%2Fdna-sequencing-is-now-improving-faster-than-moores-law%2F</link>
            <description>A &quot;worldwide genomics revolution&quot; is upon us. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586024</comments>
            <pubDate>Thu, 12 Jan 2012 18:07:57 +0100</pubDate>
            <guid isPermaLink="false">5586024</guid>        </item>
        <item>
            <title>Bill Gates: The 7 Most Influential Vaccine Heroes</title>
            <link>http://www.medworm.com/index.php?rid=5586026&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fpictures%2Fmkg45glfg%2Fbill-gates-is-the-chairman-of-the-bill-and-melinda-gates-foundation-4</link>
            <description>(Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586026</comments>
            <pubDate>Thu, 12 Jan 2012 12:28:39 +0100</pubDate>
            <guid isPermaLink="false">5586026</guid>        </item>
        <item>
            <title>Bill Gates On India's First Polio-Free Year</title>
            <link>http://www.medworm.com/index.php?rid=5586025&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F12%2Fbill-gates-on-indias-first-polio-free-year%2F</link>
            <description>Today marks the a year since the last case of new polio infection in India -- a major step toward eliminating the virus there. India is one of only four countries (the others are Pakistan, Afghanistan, and Nigeria, known by the acronym PAIN) where polio is said to be endemic, that is, spreading there, not coming from one of those four places. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586025</comments>
            <pubDate>Thu, 12 Jan 2012 12:28:39 +0100</pubDate>
            <guid isPermaLink="false">5586025</guid>        </item>
        <item>
            <title>The Obama Administration's War on Alzheimer's</title>
            <link>http://www.medworm.com/index.php?rid=5600085&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fhowardgleckman%2F2012%2F01%2F11%2Fthe-obama-administrations-war-on-alzheimers%2F</link>
            <description>On Monday, a presidential advisory group set a goal to prevent and effectively treat Alzheimer's Disease by 2025. There is much to like about this proposal, but it should come with a consumer warning: There is a lot less to this plan than meets the eye. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600085</comments>
            <pubDate>Wed, 11 Jan 2012 22:59:39 +0100</pubDate>
            <guid isPermaLink="false">5600085</guid>        </item>
        <item>
            <title>Millennials Divorce Marriage</title>
            <link>http://www.medworm.com/index.php?rid=5586027&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fprospernow%2F2012%2F01%2F11%2Fmillennials-divorce-marriage%2F</link>
            <description>The facts are in but they offer so many twists and inferences that it’s difficult to bring the entire picture into HD focus. No matter how you hold the lens of personal bias Millennials seem to be determined to divorce themselves from marriage. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586027</comments>
            <pubDate>Wed, 11 Jan 2012 22:21:21 +0100</pubDate>
            <guid isPermaLink="false">5586027</guid>        </item>
        <item>
            <title>ASSERT Sheds Light on the Role of Subclinical AF in Stroke</title>
            <link>http://www.medworm.com/index.php?rid=5586028&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F11%2Fassert-sheds-light-on-the-role-of-subclinical-af-in-stroke%2F</link>
            <description>A new study&amp;nbsp;published in the&amp;nbsp;New England Journal of Medicine sheds some much-needed light on the&amp;nbsp;precise role of subclinical atrial fibrillation (AF) in the prognosis and development of ischemic stroke.&amp;nbsp;ASSERT (Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial) followed 2580 patients with a newly implanted pacemaker or ICD and with no previous diagnosis of AF. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586028</comments>
            <pubDate>Wed, 11 Jan 2012 22:00:36 +0100</pubDate>
            <guid isPermaLink="false">5586028</guid>        </item>
        <item>
            <title>Director of UConn CV Research Center Accused of Scientific Misconduct</title>
            <link>http://www.medworm.com/index.php?rid=5586029&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F11%2Fdirector-of-uconn-cv-research-center-accused-of-scientific-misconduct%2F</link>
            <description>Updated-- Following an extensive investigation, Depak Das,&amp;nbsp;a professor in the Department of Surgery and director of the Cardiovascular Research Center at the University of Connecticut Health Center, has been accused of serious scientific misconduct. UConn has informed 11 scientific journals about the investigation. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586029</comments>
            <pubDate>Wed, 11 Jan 2012 18:36:00 +0100</pubDate>
            <guid isPermaLink="false">5586029</guid>        </item>
        <item>
            <title>Offshore Voluntary Disclosure Part III -- Yet Another Last Chance for Taxpayers</title>
            <link>http://www.medworm.com/index.php?rid=5586030&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Finsider%2F2012%2F01%2F11%2Foffshore-voluntary-disclosure-part-iii-yet-another-last-chance-for-taxpayers%2F</link>
            <description>The IRS just announced plans to reopen its Offshore Voluntary Disclosure Program (the “OVDP”) giving taxpayers a third “last” chance to come clean with their previously undisclosed offshore accounts.&amp;nbsp; While the IRS’s two previous programs generated 33,000 disclosures and $4.4 billion in revenues, it is reasonable to ask why accountholders who did not come forward before would participate in the reopened OVDP.&amp;nbsp; Indeed, history suggests that taxpayers are more likely to seek absolution if they have a genuine fear of detection. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586030</comments>
            <pubDate>Wed, 11 Jan 2012 16:37:37 +0100</pubDate>
            <guid isPermaLink="false">5586030</guid>        </item>
        <item>
            <title>Isis CEO Predicts Success For His Cholesterol Medicine -- And Substantial Delays For Regeneron, Pfizer And Amgen</title>
            <link>http://www.medworm.com/index.php?rid=5586031&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F11%2Fisis-ceo-predicts-success-for-his-cholesterol-medicine-and-substantial-delays-for-regeneron-pfizer-and-amgen%2F</link>
            <description>Isis Pharmaceuticals chief executive Stanley Crooke thinks that Wall Street is wildly undervaluing the cholesterol drug he is developing with drug giant Sanofi's Genzyme unit – and that there may be substantial delays for another type of medicine that could be a competitor down the road. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586031</comments>
            <pubDate>Wed, 11 Jan 2012 16:11:29 +0100</pubDate>
            <guid isPermaLink="false">5586031</guid>        </item>
        <item>
            <title>Is the Individual Mandate Severable?</title>
            <link>http://www.medworm.com/index.php?rid=5586032&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Faroy%2F2012%2F01%2F10%2Fis-the-individual-mandate-severable%2F</link>
            <description>When the Supreme Court considers the health care reform law in March, one of the main issues will be whether the “individual mandate” – the requirement to obtain government-approved health insurance or pay a penalty – is constitutional. If it's not, the next issue will be whether it is possible to hold the individual mandate unconstitutional, but let the rest of the health care law – or at least most of it – stand without the mandate. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586032</comments>
            <pubDate>Tue, 10 Jan 2012 23:07:24 +0100</pubDate>
            <guid isPermaLink="false">5586032</guid>        </item>
        <item>
            <title>The Novartis Shutdown Could Cost How Much?</title>
            <link>http://www.medworm.com/index.php?rid=5600086&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fedsilverman%2F2012%2F01%2F10%2F254%2F</link>
            <description>Over the past month, Novartis has worked hard to downplay the unexpected shutdown of a key manufacturing plant in Lincoln, Nebraska, where the drugmaker produces an assortment of widely used over-the-counter medicines and animal health drugs. In announcing the closure, Novartis noted that combined annual sales of the products made at the facility amount to less than 2 percent of Novartis group sales overall (see here). (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5600086</comments>
            <pubDate>Tue, 10 Jan 2012 21:27:20 +0100</pubDate>
            <guid isPermaLink="false">5600086</guid>        </item>
        <item>
            <title>Today's Coolest New Gadget Is, In Fact, At CES</title>
            <link>http://www.medworm.com/index.php?rid=5586033&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2012%2F01%2F10%2Ftodays-coolest-new-gadget-is-not-at-ces%2F</link>
            <description>It's the Ion Proton DNA sequencer. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586033</comments>
            <pubDate>Tue, 10 Jan 2012 21:13:10 +0100</pubDate>
            <guid isPermaLink="false">5586033</guid>        </item>
        <item>
            <title>Researchers Find Lower Sweet Spot for Potassium Levels in MI</title>
            <link>http://www.medworm.com/index.php?rid=5586034&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F01%2F10%2Fresearcher-find-lower-sweet-spot-for-potassium-levels-in-mi%2F</link>
            <description>Current guidelines for the treatment of acute MI recommend that serum potassium be maintained between 4.0 and 5.0 mEq/L, and some believe that the upper limit could be raised to 5.5, but evidence is based on small, outdated studies. Now a new study published in JAMA suggests that the ideal potassium range should be adjusted downward. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586034</comments>
            <pubDate>Tue, 10 Jan 2012 21:00:33 +0100</pubDate>
            <guid isPermaLink="false">5586034</guid>        </item>
        <item>
            <title>Options Players Bullish On Brocade, Bet On WebMD Recovery</title>
            <link>http://www.medworm.com/index.php?rid=5586035&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fgreatspeculations%2F2012%2F01%2F10%2Foptions-players-bullish-on-brocade-bet-on-webmd-recovery%2F</link>
            <description>Today’s tickers: WBMD, AMAT &amp; BRCD (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586035</comments>
            <pubDate>Tue, 10 Jan 2012 19:14:55 +0100</pubDate>
            <guid isPermaLink="false">5586035</guid>        </item>
        <item>
            <title>Medicis Pharmaceutical Downgraded to HOLD</title>
            <link>http://www.medworm.com/index.php?rid=5586036&amp;cid=s_22566_34_f&amp;fid=22566&amp;url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fcanaccordgenuity%2F2012%2F01%2F10%2Fmedicis-pharmaceutical-downgraded-to-hold%2F</link>
            <description>Canaccord Genuity specialty pharmaceutical analyst Randall Stanicky downgraded his rating on&amp;nbsp; Medicis Pharmaceutical Corp.&amp;nbsp;(MRX) shares to HOLD from BUY and lowered his price target to $36 from $38. Of MRX, Mr. Stanicky said: (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5586036</comments>
            <pubDate>Tue, 10 Jan 2012 18:19:02 +0100</pubDate>
            <guid isPermaLink="false">5586036</guid>        </item>
    </channel>
</rss>

